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DNA methylation at cytosine (5meC) is essential for central cellular mechanisms, 
such as genomic imprinting, tissue-specific gene expression, silencing of retroviral 
elements and inactivation of the X chromosome in female. Impairment of proteins that 
either deposit or bind the 5meC leads to human disease, such as imprinting disorders, 
Rett Syndrome, Immunodeficiency Centromeric instability and facial abnormalities (ICF) 
syndrome and cancer.  
DNA methyl transferases (DNMTs) are directly responsible for the deposition of 
methyl groups on the DNA and can be divided into de novo and maintenance DNMTs, 
accordingly to structural and functional features. The de novo DNMTs are responsible for 
depositing methyl groups on non-methylated DNA, mostly in the form of heterochromatin. 
The maintenance DNMTs methylate hemimethylated DNA at the replication fork, and are 
thereby responsible for preventing the loss of 5meC during cell division. These proteins 
are crucial during embryonic development, since DNA methylation goes through severe 
reprogramming events. In fact, 5meC is almost completely lost after 3.5 days from the 
fertilisation and is re-established by day 6.5 of the embryonic development, when the 
epiblast is formed. From day 3.5 the de novo DNMTs, DNMT3B and DNMT3A, are highly 
expressed and methylate the genome. The maintenance DNMT1 is then expressed and 
maintains the newly methylated genomic loci. Mutations of these proteins determine 
diseases in humans, such as the ICF syndrome. The majority of ICF patients is 
characterised by mutations in DNMT3B and hypomethylation of DNA. However, a small 
percentage of patients is characterised by mutations in the Lsh gene. 
Lymphoid Specific Helicase (LSH) is an ATP-dependent chromatin remodeler, 
whose remodeler activity has not been proven in vitro. It is essential for DNA methylation 
throughout the genome, in mammals and plants and it has been linked to developmentally 
programmed de novo methylation at unique and repetitive sequences. However, there is 
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still debate on whether LSH has a role in maintenance of DNA methylation as well. 
Knockout of Lsh gene in embryos results in ~50% reduction of 5meC in the genome. It is 
hypothesized that LSH remodels chromatin to enable the access of DNA 
methyltransferases to DNA during development, when DNA methylation patterns undergo 
dramatic reprogramming. 
In this work, by using an in vitro culturing system, we mimicked the reprogramming 
of the DNA methylation typical of embryonic development and analysed changes 
occurring in 5meC deposition and localisation in absence of LSH. To do so, we used 
mouse ESCs maintained in 2i or serum-containing culturing media. The 2i-containing 
medium was used to deplete 5meC and ensure a naïve state of pluripotency, resembling 
the methylation level in the blastocyst state; the serum-containing medium determined an 
accumulation of DNA methylation, which took the cells to a primed pluripotent state, 
resembling the epiblast. Using this system, we could analyse how cells lacking LSH 
responded to DNA methylation reprogramming. We showed that the role of LSH is 
concomitant with the de novo DNA methylation timing. Furthermore, analyses of DNA 
demethylation suggested that LSH was not involved in maintenance of DNA methylation. 
Interestingly, we found that in absence of LSH; loss and gain of methylation were faster. 
This suggested that the chromatin in cells lacking LSH was more easily accessible to 
methyltransferases and demethylases, supporting the hypothesis of an involvement of 
LSH in DNA methylation via its remodelling activity. The same system was advantageous 
to investigate on a whole genome base the genomic regions requiring LSH activity. 
Sequencing of the unmethylated fraction of the genome was carried out on cells before 
and after reprogramming of the DNA methylation and on cells in the early differentiation 
stage. This experiment confirmed the previous findings that LSH is required both at unique 
and repetitive regions of the genome, such as IAPs, and gave further insights into the 
regions that require LSH to be de novo methylated.  
In conclusion, this study has demonstrated that LSH is required only concomitantly 
to the reprogramming of DNA methylation, that occurs during early phases of embryonic 
development. Furthermore, it has provided with further evidence supporting LSH activity 
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as chromatin remodeler and facilitator of de novo methylation, but not maintenance. 
Finally, the high throughput sequencing analysis has deepened the understanding of the 









Life starts as a single cell. All the information that the cell requires to produce a 
whole organism is encoded in the DNA. A human body is made of over 37 trillion cells. 
Each one of these cells contain the same DNA, but is different and specialised in a unique 
job. How is this possible? The cell has to select the information required to accomplish its 
specific job. To do so, the DNA is modified by the addition of chemical groups. These can 
allow access to a specific piece of information or, on the contrary, stop the access to it, 
very much like a GO or STOP signal. The most important stop signal on the DNA is called 
DNA methylation. When this stop signal is not at its place, the cell has difficulties to 
specialise in doing its job and, as a result, the adult individual has health problems.  
In my work, I studied a protein called LSH. This protein works like a traffic 
policeman, helping to direct the deposition of DNA methylation. I discovered that LSH is 
important very early in the development of the embryo, working to ensure that the not 
accessible regions of the DNA remain so. I also found out that LSH preferentially works at 
some regions of the DNA. This information could provide the basic knowledge on which to 
build up to better understand what goes wrong when LSH does not work in humans and 







1.1. Epigenetic gene regulation  
 
1.1.1. History and definition      
 
Life starts as a single cell, which is formed by the maternal and paternal genomes 
among fertilization. This single cell goes through embryonic development and subsequent 
divisions and eventually enough cells to form a whole organism are produced. Importantly, 
this means that, despite the presence of a variety of specialised cell types in the adult, the 
genome of all these cells is identical. It is therefore clear that an extra layer of regulation 
exists, which influences the expression of genes and thus the production of specific 
proteins in the cells and, therefore, the differentiation and specialization processes. It is 
now known that the regulation of gene expression is controlled by a variety of mechanisms 
that are grouped under the definition of epigenetic gene regulation.  
The term epigenetic (literally, above genetics) was firstly coined by the 
developmental biologist Conrad Waddington as a result of his experiments in embryos of 
Drosophila. In 1942, he defined epigenetics as “the branch of biology that studies the 
casual interactions between genes and their products which bring the phenotype into 
being” (Waddington, 1942). Waddington’s focus at the time was on decoupling the 
genotype from the phenotype, only implying the existence of regulation. However, at his 
time these findings were considered very controversial, being assimilated into the 
Lamarkian adaptation theory that was rejected at that point. In fact, already in the 19th 
century, the evolutionary biologist Jean-Baptist Lamarck hypothesised the capability of an 
organism to acquire specific characteristics during its lifetime, as a response to 
environmental circumstances. These acquired characteristics could then be transmitted to 
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the progeny, leading to evolution by adaptation rather than by selection, as later stated by 
Charles Darwin.   
A big step into modern “molecular” epigenetics was taken by Allfrey and Minsky 
(Allfrey et al., 1964), who confirmed a role for histone in RNA synthesis. In their work, they 
proposed a mechanism of switching on and off RNA synthesis, therefore silencing and 
activating gene expression, via histone acetylation and methylation.  
Since then, the definition of epigenetics has changed to include the further 
knowledge acquired during the years. In 1994, Holliday offered two definitions for the term, 
including the concept of inheritance and the idea that these differences were not part of 
the DNA sequence (Holliday, 1994; Bird, 2002; Jaenisch & Bird, 2003). Russo, in 1996, 
took Holliday’s definition and re-elaborated it into what is now probably the most 
commonly used definition in the field: “the structural adaptation of chromosomal regions so 
as to register, signal or perpetuate altered activity states” (Bird, 2007).  
Even though the interest in epigenetics has started long ago, it is only in the past 20 
years that this had become a hot topic in biology. The genome projects have expanded 
vastly the knowledge of the DNA sequence for different organisms. This, together with 
technical advances, enabled delineation of the epigenetics differences on a whole-
genome level. It is now commonly agreed that there are 2 main epigenetic mechanisms 
that regulate gene expression: deposition of epigenetic marks, namely methylation of the 
DNA on the cytosine bases and modification of histone tails, and RNA-based 
mechanisms, such as noncoding RNAs and microRNAs.   
Although big steps forward have been made, there is still a lot to be uncovered 
regarding how these modifications affect gene expression, how the modifications are 
transmitted to the progeny and how the epigenome can be influenced by the environment.  
 
1.1.2. Types of epigenetic modifications: DNA and histone modifications 
 
The DNA contained within each cell nucleus is very long, especially if compared to 
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the size of a cell, and contains a great amount of information. It is therefore important to 
properly package it, at the same time avoiding damages, while allowing accessibility to the 
necessary piece of information. To do so, the DNA is wrapped around histone proteins 
forming nucleosomes (Figure 1.1) (Kornberg, 1974; Längst & Manelyte, 2015). These are 
the core unit of chromatin and are formed by an octamer containing two copies of each 
histone protein, including H2A, H2B, H3 and H4, around which 147bp of DNA are 
wrapped. Nucleosomes are separated by linker DNA, whose length is species and cell 
type specific, and which is bound by the linker histone H1 (Bednar et al., 1998). 
Positioning of nucleosomes on the DNA determine accessibility of the information 
encoded in a specific genomic region and depends on the interplay between different 
factors, namely DNA sequence, DNA-binding proteins, nucleosomes remodelling proteins 
and finally RNA polymerase II machinery (Struhl & Segal, 2013). Depending on the 
accessibility of the chromatin, this can be classified as euchromatin or heterochromatin. 
Euchromatic regions are characterised by regularly positioned and interspaced 
nucleosomes and contain actively transcribed genes. On the contrary, in heterochromatic 
regions nucleosomes are densely positioned, forming a physical barrier to the DNA for 
transcription factors and thereby preventing gene expression. Importantly, some 
heterochromatic regions retain the capability to convert to euchromatin, depending for 
example on the developmental stage. These regions are named facultative 
heterochromatin, in contrast with constitutive heterochromatin, which includes regions that 
must not be expressed, such as repetitive sequences or non-coding centromeric DNA 
(Trojer & Reinberg, 2007). Deposition of epigenetic marks is crucial for the correct 
organisation of chromatin and consequently for gene expression regulation.  
Epigenetic marks are covalent modification of either the DNA or histones and can 
play a role of activators and repressors of gene expression. It is now well known that gene 
expression is not an on/off mechanism. In fact, to finely regulate this process, not only the 
deposition of a single epigenetic mark is important, but also where this mark is deposited 
and how it interacts with the marks in the close proximity.   
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Figure 1.1 Organisation of chromatin in mammalian cells. 
Schematic representation of the organisation of chromatin in the nucleus. DNA is wrapped around
nucleosomes, which are then compacted into forming chromatin and, during mitosis, chromosomes.
The epigenetic modifications contributing to the regulation of gene expression are annotated: methylation
of the DNA and modifications of histone tails. Red dots represent methyl groups on the DNA, red elipses
represent methyl groups on histone tails, green elipses represent acetylated groups on histone tails. Yellow 
sticks represents Adenines, orange sticks represents Thymines, light green sticks represents Cytosines, 















The most abundant modification of the DNA is the methylation of the 5th carbon of 
the cytosine (5meC) (Bird, 2002; Jaenisch & Bird, 2003; Smith & Meissner, 2013). The 
methylation of the Cs is achieved via transfer of a methyl group from the donor S-
adenosylmethionine (SAM) by a DNA methyltransferase (DNMT) enzyme (Figure 1.3A). 
DNA methylation is mostly abundant in the context of Cytosine-Guanine dinucleotide 
(CpG), but can also occur at CH, CHH and CHG, where H is any nucleotide but G (Lister 
et al., 2009). It often acquires a repressive meaning for gene expression. However, it was 
shown that the effect of 5meC on gene expression varies and is dependent on the 
localisation of the mark (Jones, 2012). In fact, if methylation at CGIs is repressive, there is 
increased evidence that DNA methylation at gene bodies can have a positive effect in the 
regulation of transcription, facilitating elongation and splicing (Jones, 2012; Maunakea et 
al., 2013; Yearim et al., 2015; Neri et al., 2017).  This mark can be removed from the DNA, 
through the production of an oxidised form of the modification, hydroxy-methylcytosine 
(5hmeC) (Tan & Manley, 2009). Despite being much less abundant, this modification is 
now considered a very important epigenetic mark, especially when studying the dynamics 
of the 5meC in early phases of mammalian development or in diseases.  
The second category of epigenetic marks includes modifications of histone N-
terminal or C-terminal tails, protruding out of the nucleosome core particle. These 
posttranslational modifications can involve the addition of either a small chemical group, 
methylation, phosphorylation or acetylation, or of a peptide, such as sumoylation or 
ubiquitination, (Figure 1.2) (Rodríguez-Paredes & Esteller, 2011). Some of these 
modifications can be very abundant in the genome and are crucial not only for the correct 
regulation of the transcription, but also for the organisation of high level of chromatin 
compaction within the nucleus. Importantly, histone and DNA modifications are not 
independent epigenetic modifications, but interact to regulate the expression of genes and 






1.1.3. Histone modifications: acetylation and methylation 
 
It is now well established that the deposition of histone modifications is finely 
regulated and that the response to these marks depends on the specific residue that is 
modified, the localisation of the mark in the genome and also on the number of chemical 
groups that are added to the modified residues. It is therefore very important not only to 
obtain such information, but also to consider the interplay between different modifications. 
One of the most striking examples of how antagonistic histone modifications collaborate in 
regulating gene expression are bivalent domains (Harikumar & Meshorer, 2015; Voigt et 
Figure 1.2 Histone tail modifications 
A.Schematic representation of the most common modifications found on histone tails. Positions of the 
modification on specific residues are shown by the presence of a colour-coded flag. Histone modifications 
relevant to my work are located on Histone 3 (H3). Numbers under the residues indicate the position that 













al., 2013). These are genomic regions characterised by the modifications of histone tails in 
an asymmetric fashion, with a repressive methylation and an active methylation mark that 
occupy opposite H3 tails. A lot of work has been done to shed some light on this 
regulatory mechanism and it has been proposed that these apparently contradictorily 
signalling marks poise genes, that keep a low expression and are reversibly silenced, thus 
allowing a quick activation or stable silencing in case of a sudden stimulus or during 
differentiation (Bernstein et al., 2006; Voigt et al., 2013). 
Histone acetylation is one of the most studied histone modifications and is 
maintained between organisms, from humans to yeast and Drosophila. It is deposited on 
lysines by histone acetyltransferases (HATs), that use the acetyl-Coenzyme A (acetyl-
CoA) as a cofactor and transfer an acetyl group on the histone. This neutralises the 
positive charges of the lysine residues and weakens the interaction between histone and 
DNA. It is a mark of transcription activation, a feature highlighted already in the 1960s by 
Allfrey (Bannister & Kouzarides, 2011; Kouzarides, 2007). In fact, acetylated lysines are 
signature of euchromatic regions and specifically found at enhancers and promoters of 
active genes, while the gene bodies are hypo-acetylated. The equilibrium between 
acetylated and hypoacetylated state is guaranteed by the activity of HATs and histone 
deacetylases (HDACs). The oppose action of HDACs restores the positive charge of the 
lysine and is supposed to stabilise the architecture of the chromatin and lead to repression 
of gene expression. The balance between HATs and HDACs activity is very important for 
regulation of transcription, DNA replication and DNA repair. An example of acetylation 
activity in gene expression was recently published. More specifically, during differentiation 
of ESCs towards the neural lineage, H3ac is increased at neuronal gene and is vice versa 
decreased in neuronal-inhibiting loci (Liu et al., 2015). 
Histone tails can also be modified by addition of one, two or three methyl groups. 
Methylation can occur at lysine or arginine residues and can either positively or negatively 
affect gene expression (Bannister & Kouzarides, 2011; Harikumar & Meshorer, 2015; 
Martin & Zhang, 2005). Lysine 9 and 27 methylation are a common signature of 
heterochromatic regions and occurs at inactive genes and repetitive elements. On the 
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contrary, the methylation of Lysine 4 on histone H3 (H3K4me3) is a mark associated with 
active transcription. As aforementioned, the silencing histone 3 lysine 27 tri-methylation 
(H3K27me3) and the activating H3K4me3 marks can coexist at bivalent domains 
(Harikumar & Meshorer, 2015; Voigt et al., 2013). There is a variety of lysines/arginine 
methyl transferases (K/RMTs) complexes, catalysing the deposition of a methyl-group 
from S-adenosyl methionine (SAM) to specific substrates. The first histone KMT to be 
discovered was SUV39H1, a histone methyltransferase that trimethylates lysine 9 on 
histone 3, has a SET domain and contributes to formation of constitutive heterochromatin 
(Aagaard, 1999; Li et al., 2009). Subsequently, more SET and non-SET KMTs were 
discovered (Bannister & Kouzarides, 2011; Martin & Zhang, 2005). Among these, 
SUVAR39H1/2, ESET and G9a/GLP are specific for Histone 3 Lysine 9 methylation 
(H3K9me), while the Polycomb repressive complex 2 (PRC2) is mainly responsible for 
Histone 3 Lysine 27 tri-methylation (H3K27me3), via its EZH2 subunit. These protein 
complexes contribute to silencing of gene expression, by enabling “readers” of the 
epigenetic modification to bind and start repression, such as the heterochromatin protein 1 
(HP1) or the Polycomb protein EED (Yun et al., 2011). On the other hand, mixed lineage 
leukaemia (MLLs) and SET1A and B are specific for H3K4me3 and are therefore 
considered facilitators of transcriptional activation. Histone methylation can be erased by 
demethylases enzymes, such as LSD1 (lysine (K)-specific demethylase 1A), JMJDs 
(Jumonji domain-containing proteins) and JHDMs (Jumonji C domain-containing histone 
demethylases). 
It is not hard to believe that, in many instances, histone methylation and DNA 
methylation have been shown to be indispensable for each other, especially when 
organising the compaction of the chromatin and therefore establishing transcriptional 
silencing. While in organisms such as Neurospora Crassa, a mould, this link is 
unidirectional from histones to DNA modification, through HP1 (Du et al., 2015), in 
mammals it is bidirectional. In mammals, this interaction can be bridged by proteins which 
recognise DNA methylation through their Methyl-CpG Binding Domain (MBD1-4 and 
MeCP2). For example, MBD1 can recruit ESET to newly synthesised DNA and thereby 
 21 
participate in the maintenance of H3K9 methylation during cell division (Rose & Klose, 
2014; Sarraf & Stancheva, 2004). MDB1 was also shown to interact with Suv39h1 and 
HP1, which recruit HDACs, and coordinate transcriptional repression (Fujita et al., 2003; 
Rose & Klose, 2014). On the contrary, evidence of DNA methylation dependent on histone 
methylation is given for example by the recruitment of the de novo DNMTs by G9a/GLP 
complex. This cascade is important to antagonise demethylation of the DNA at imprinted 
loci (Zhang et al., 2016).    
 Due to the very complicated and interlinked relationship between DNA and histone 
methylation, it remains unclear the order of events, that leads to gene transcriptional 
repression and change in chromatin architecture and could be applicable to all instances. 
While in N. crassa, as aforementioned, DNA methylation always depends on histone 
methylation (Du et al., 2015), in mammals, DNMTs seems to recognise heterochromatin 
through direct interaction with histone methyltransferases, such as Suv39h1, Eset and 
G9a/GLP (Rose & Klose, 2014). However, knock out in cancer cell lines of Dnmt1 gene 
was shown to lead to loss of H3K9me, suggesting the dependence of histone methylation 
on DNA methylation (Espada et al., 2004; Rose & Klose, 2014). 
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Appendix Table 1.BioCAP-sequencing quality control. 
In the first column, samples sequenced are listed: HT = Lshoff/+ KO = Lshoff/off .
In the second column, the percentage of duplicates is indicated.
In the third column, the percentage of GC in each sample is indicated. 
In the fourth column, the milion of reads sequenced per each sample is indicated.  
Table 1.Control of DNA methylation. 
Brief summary of the main proteins that participate into DNA methylation control, as
writers, readers or erasers. In the last column, references of main works on the proteins
and figures in this thesis work.
Table 2.LSH knock-outs. 
Brief summary of the main knock-outs models for LSH in mice. The first works regarding the 
mouse model are listed in the first column. The approaches used to produce the KOs are
indicated in the second and third columns. In the last column a brief description of the 
phenotipe of the mouse model is reported. 
 22 
1.2. DNA methylation 
 
1.2.1. Characterization of DNA methylation in the mammalian genome 
 
One of the main regulatory marks for gene repression is the methylation of the fifth 
carbon of the cytosine (5meC). This was first detected in calf thymus DNA by paper 
chromatography in 1948 (Hotchkiss, 1948). However, it took almost two decades to 
understand the importance of this modification (Compere & Palmiter, 1981; Holliday & 
Pugh, 1975).  
DNA methylation on the cytosine is found in fungi, plants and animals, and can be 
inherited by the next generation of individuals. However, pattern and even presence of 
DNA methylation varies among different species (Table 2). As for its presence, it can be 
stated that 5meC is found in all groups of eukaryotes, namely protists, fungi, plants and 
animals, but it is absent in some species, such as the common laboratory animal models 
Caenorhabditis elegans and Drosophila melanogaster. Furthermore, two main patterns of 
5meC in the genome have been identified: mosaic or whole genome (Aliaga et al., 2019; 
Colot & Rossignol, 1999). In invertebrates, 5meC is mainly spread in a mosaic-fashion, 
where regions with high methylation are alternated with regions completely depleted of the 
modification. In contrast, in invertebrates, DNA methylation is mostly distributed 
throughout the whole genome and depleted only at regulatory elements (Aliaga et al., 
2019; Capuano et al., 2014; Colot & Rossignol, 1999). Importantly, DNA methylation is 
very abundant in the mammalian genome. In fact, 70 to 80% of cytosines in the context of 
CpG dinucleotide are methylated in mammals (Law & Jacobsen, 2011). Most CpG islands 
(CGIs), CpG rich regions, of maximum 1kb length and commonly found at transcription 
start sites, but also in gene bodies and intergenic regions, are normally depleted of 
methylation. If CGIs become methylated, this leads to long-term silencing of the 
associated genes (Jones, 2012). Methylation outside of CGIs is more common and usually 
more dynamic and tissue-specific (Jones, 2012).  
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Group DNA methylation Exceptions 
Plants Yes, on Cs in CpG and 
non-CpG context. 
Abundant at repetitive 
elements. 
• Chlamydomonas reinhardtii (Lopez et 
al., 2015): low level of methylation in the 
nuclear genome, abundant 5meC in the 
chloroplast genome. Hypermethylation in 
gametes and zygote.  
Fungi Yes, on Cs in CpG and 
non-CpG context. 
Abundant at repetitive 
elements. 
• Saccharomyces cerevisiae (Capuano et 
al., 2014): liquid chromatography 
analyses show no DNA methylation in 
commercially and laboratory yeast 
strains. 
Animals Yes, mainly on Cs in 
CpG context. Abundant 
at repetitive elements. 
• Caenorhabditis elegans (Greer et al., 
2015): no 5meC, but 6mA (methylation 
of the 6th N of Adenine).  
• Drosophila melanogaster(G. Zhang et 
al., 2015) : extremely low level of 5meC, 






While non-CpG methylation is widespread in plants (Law & Jacobsen, 2011), and 
has been observed in mammals (Ramsahoye et al., 2000), CpG methylation remains the 
most important modification, since it is more abundant and is involved in a variety of 
cellular mechanism. More specifically, 5meC is important during development to regulate 
gene expression in a tissue-specific manner and for genomic imprinting, by regulating the 
parent-of-origin expression of specific alleles. Furthermore, it is crucial for preserving 
genome stability and integrity by silencing endogenous retrotransposons. Finally, it is 
involved in inactivation of X-chromosome in female mammals, on which silenced genes 
are DNA methylated (Bird, 2002; Jaenisch & Bird, 2003). As a consequence of its 
involvement in these processes essential for cells and organisms, misregulation of this 
mark, via mutations in proteins involved in the methyl group deposition or in the binding to 
5meC, results in diseases. Some examples are imprinting disorders; Immunodeficiency, 
Appendix Table 1.BioCAP-sequencing quality control. 
In the first column, samples sequenced are listed: HT = Lshoff/+ KO = Lshoff/off .
In the second column, the percentage of duplicates is indicated.
In the third column, the percentage of GC in each sample is indicated. 
In the fourth column, the milion of reads sequenced per each sample is indicated.  
Table 1.Control of DNA me hylation. 
Brief summary of the main proteins that participate into D A methylation control, as
writers, readers or erasers. In the last column, refe ences of ain work  on the proteins
and figures in this thesis work.
Table 3.LSH knock-outs. 
Brief summary of the main knock-outs models for LSH in mice. The first works regarding the 
mouse model are listed in the first column. The approaches used to produce the KOs are
indicated in the second and third columns. In the last column a brief description of the 
phenotipe of the mouse model is reported. 
Table 2.DNA methylation in different living organisms. 
Brief summary of the characteristics of DNA methylation in different groups of eukaryotes.
5meC patterns are very variable among different species, therefore in the last column 
some species are listed as examples of exceptions to the characteristics of their group.
 24 
Centromeric instability and Facial abnormalities (ICF) syndrome, characterised by 
mutations in DNMT3B, LSH and CDCA7; Rett Syndrome, determined by mutations in 
MeCP2; Lupus and cancer (Reik, 2007; De Sario, 2009; Smith & Meissner, 2013). 
Methylation of the DNA is catalysed by a group of enzymes called DNA methyl 
transferases (DNMTs), also defined as “writers” of the DNA methylation (Goll & Bestor, 
2005). These enzymes use SAM as a donor of the methyl group, which is then transferred 
to the 5th carbon group of the cytosine leading to the formation of 5meC and the release of 
SAH (Figure 1.3A). The deposition can occur on unmodified DNA, mechanism defined as 
de novo methylation, by the de novo methyl transferases DNMT3A and DNMT3B. On the 
other hand, when DNA is duplicated, the newly synthesised strand is unmodified, while the 
complement strand keeps the modification. DNMT1 is the maintenance methyl 
transferase, capable of methylating hemimethylated DNA at heterochromatic regions and 
at the replication fork (Figure 1.3B).  
Despite a lot of work that has been done to elucidate the mechanisms by which the 
5meC is involved in the regulation of gene expression, there are yet questions to be 
answered. In particular, it is very important to fully understand how the methylation is 
deposited and regulated during the early phases of embryonic development. In fact, this 
would allow a better understanding of what goes wrong in human diseases and would 
possibly open new routes in the treatment of these patients. 
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Figure 1.3 DNA methylation 
A.Schematic representation of the chemical reaction occuring at cytosine when a methyl group is deposit. 
SAM is the methyl group donor. The CH3 is then transfered on the 5th carbon of the cytosine ring, and SAH
is released.
B.Naked DNA is methylated by the de novo methyltransferases DNMT3A and DNMT3B. At replication, 
the maintenance DNA methyltransferase DNMT1 symmetrically methylates the newly synthesised
DNA strand. Removal of methyl groups occurs actively by the TET enzymes or passively, by lack of 



























1.2.2. De Novo DNA methylation and DNA Methyltransferases 
 
DNMTs are capable of depositing a methyl group onto the cytosine. However, the 
two groups of methyltransferases, de novo and maintenance, differ in their substrate 
specificity. In fact, while DNMT1 propagates the methylation concomitantly with cell 
division and has a specific activity for hemimethylated DNA, DNMT3s have affinity for 
hemi and non-methylated DNA (Okano et al., 1999). 
The main methyltransferases involved in de novo methylation are DNMT3A, 
DNMT3B and DNMT3L (Okano et al., 1999). The DNMT3A and DNMT3B have a very 
similar multidomain structure: a C-terminal catalytic domain; the ADD domain, responsible 
for DNA binding through a conserved amino acid sequence; a variable N-terminal domain, 
containing regulatory regions and a PWWP domain, responsible for the recognition of 
histone 3 lysine 36 tri-methylated (H3K36me3) (Goll & Bestor, 2005). DNMT3L is a much 
smaller protein, completely lacking the PWWP domain and is thereby considered an 
inactive member of this family of protein. In fact, DNMT3L is important in guiding DNMT3A 
during methylation in gametes, but has no direct methyl transferase activity (He et al., 
2011). 
Despite the similar structure, DNMT3A and DNMT3B have distinct biological roles 
and targets in the genome. Evidence of this are found in studies in knock out models for 
Dnmt3a and Dnmt3b, that showed different phenotypes in mice (Li et al., 1992; Smith & 
Meissner, 2013). More specifically, mice lacking DNMT3A can normally develop to birth, 
but die shortly after. However, absence of DNMT3B is embryonic lethal and determines 
severe defects in the development of the embryo. 
DNMT3A is expressed earlier in the zygote and is fundamental for the methylation of 
maternal and paternal imprints, with the help of DNMT3L (Figure 1.5A) (Law & Jacobsen, 
2011; Smith & Meissner, 2013). On the other hand, DNMT3B has the biggest contribution 
to the de novo methylation later in the embryonic development, that occurs during 
implantation following the almost complete erasure of 5meC at the blastocyst stage 
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(methylation dynamics in the early development will be discussed later in this chapter).  
A newly discovered de novo methyltransferase is DNMT3C. This enzyme seems to 
be crucial for the regulation of DNA methylation at retrotransposons in male germ cells 
(Barau et al., 2016).  
While de novo methylation occurs mostly during embryonic development, gene 
silencing via DNA methylation deposition is important for lineage commitment and 
differentiation. In fact, conditional knock outs of the de novo methyltransferases in mouse 
Embryonic Stem Cells (mESCs) do not lead to cell death. However, when cells are 
pushed towards lineage commitment, these are not capable of keeping the pluripotency 
genes silenced and die (Ambrosi et al., 2017).  
DNMT3s act on DNA that does not present any DNA methylation. However, this 
does not mean that the DNA that gets methylated is completely naked. In fact, although it 
is not clear yet, it is now commonly agreed that DNA methylation arrives only after the 
deposition of other epigenetic marks, such as histone methylation. The PWWP domain of 
DNMT3s can in fact recognise H3K36 methylation, which directs the protein to the gene 
body (Baubec et al., 2015; Neri et al., 2017; Rondelet et al., 2016). This co-occurrence not 
only indicates the importance of the interplay between epigenetic marks, but also suggests 
that the de novo methyltransferases have to deposit methyl groups on chromatin that is 
already tightly packed around histones. Interestingly, studies in vitro have shown that the 
activity of the DNMT3s for compacted chromatin is lower if compared to the activity on 
naked DNA (Felle et al., 2011; Robertson et al., 2004). Therefore, before methylating the 
DNA, these proteins require the activity of a different category of enzymes, the chromatin 
modifiers and chromatin remodelers. The latter support DNA methylation by facilitating the 
access to the chromatin for the DNMTs, by sliding or unwrapping a nucleosome or evicting 
a histone octamer. Among these proteins, the Lymphoid Specific Helicase (LSH) will be 




1.2.3. Maintenance of DNA methylation and maintenance machinery 
 
During mitosis, cells duplicate their DNA by using the original strands as templates. 
It is important at this stage to properly modify the newly synthesized DNA strand in order 
to preserve the epigenetic state of the loci in the new cell. In order to do so, the DNA 
methylation maintenance machinery is used. The DNA methyl transferase involved in this 
process is DNMT1, the first to be discovered and most abundant in the cells among all 
DNMTs. Despite being involved in de novo DNA methylation, via interaction with DNMT3A 
(Ambrosi et al., 2017; Law & Jacobsen, 2011), DNMT1 has a high specificity for 
hemimethylated DNA, guaranteed by auto-inhibition among binding of unmethylated DNA, 
and is capable to then methylate the newly synthesised and un-modified strand. 
Importantly, it was shown that Dnmt1-/- ESCs undergo apoptosis when induced to 
differentiate and Dnmt1-/- embryos die at day 9.5 of embryonic development (Ambrosi et 
al., 2017; Law & Jacobsen, 2011; Li et al., 1992), indicating the importance of this enzyme 
for the survival of the embryo.  
Other enzymes are also crucial for maintaining the DNA methylation. First of all, it 
was shown that in mESC lacking the de novo methyltransferases, DNMT1 is not able to 
maintain on its own the DNA methylation, suggesting a role for DNMT3s into maintenance 
and that DNMT1 is necessary but not sufficient for its role (Ambrosi et al., 2017; Chen et 
al., 2003; Liang et al., 2002). Furthermore, DNMT1 is recruited to the replication forks by 
UHRF1 (Ubiquitin Like With PHD And Ring Finger Domains 1, called Np95 in mouse). The 
methylated H3K9-like present at the N-terminal domain of the DNA ligase 1 (LIG1) binds 
UHRF1 and recruits DNMT1, ensuring maintenance of DNA methylation (Ferry et al., 
2017). This newly highlighted interaction between LIG1 and UHRF1 also showed a new 
role for lysine methylation in maintenance of DNA methylation. In fact, the N-terminal 
domain of LIG1 is a histone mimicking site, methylated by a histone methyl transferases, 
G9a, in complex with GLP.  
G9a and GLP are highly related and are lysine methyl transferases (KMTs) 
containing a SET domain. These belong to the same family of KMTs as SUV39H1 and H2, 
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SETDB1/ESET and PRDM3 and 16 (Dong et al., 2008; Jurkowska et al., 2011) and can 
methylate non-histone proteins as well. However, G9a and GLP are specifically 
responsible for the deposition of mono and di-methylation on H3 lysine 9. G9a is most 
commonly found as either a homodimer or heterodimer with GLP (G9a Like Protein), but 
in ESCs the most abundant form of the complex is the heterodimer of G9a with GLP 
formed via their C-terminal catalytic domains (Shinkai & Tachibana, 2011). The dimer is 
directed to DNA by the WIZ protein, which also acts as a stabiliser of the complex (Bian et 
al., 2015). The knock outs of G9a and Glp in mice result in embryonic lethality (Shinkai & 
Tachibana, 2011). Mice carrying a catalytically inactive form of G9a have a similar 
phenotype to the KOs for G9a/Glp, with embryonic lethality. This highlights the 
impossibility to proceed through the development in absence of G9a mediated H3K9me2.  
Importantly, the interplay between DNA methylation and histone methylation by 
G9a/GLP has been extensively studied. As mentioned above, it was very recently 
highlighted a role of this complex in methylating LIG1 and thereby recruiting UHRF1, 
which is a crucial step for the correct maintenance of DNA methylation (Ferry et al., 2017). 
A role for G9a in DNA methylation was firstly shown by the direct interaction of G9a with 
DNMT3A and 3B via its ankyrin domain (Epsztejn-Litman et al., 2008). The same domain 
is important for G9a role in protecting imprinting control regions, for which its catalytic 
activity is not required (Zhang et al., 2016). This activity in maintenance was shown at 
other loci in the genome, such as promoters (Myant et al., 2011) and retrotransposons 
(Dong et al., 2008). On the other hand, the deposition of H3K9me1/2 by G9a/GLP is 
crucial for gene repression and silencing of enhancers in the inner cell mass (ICM) during 
mouse development (Zylicz et al., 2015).  
 
 
1.2.4. Removal of DNA methylation: DNA hydroxyl-methylation and TET enzymes 
 
The final important way cells control DNA methylation is via its removal. It is in fact 
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crucial to specifically remove methyl groups from the DNA in order to reactivate gene 
expression, for instance during germ cell development, transition to pluripotency and 
during differentiation. Removal of DNA methylation occurs mainly via two routes: passive 
demethylation and active demethylation (Bhutani et al., 2011; Moore et al., 2013).  
Passive demethylation is mainly linked to DNA replication. In fact, when cells 
duplicate the DNA, as discussed earlier, the newly synthesised DNA strand is unmodified 
(Figure 1.3B). Therefore, the DNA maintenance machinery acts to establish the 
symmetrical modification. However, if this machinery is inefficient or impaired, the resulting 
DNA will stay hemimethylated (Figure 1.3B). At the next round of cell division, the 
methylation will be completely lost on the DNA synthesised using the unmethylated strand 
as a template, and so on and so forth. This mechanism is mainly responsible for the loss 
of methylation mainly of the maternal genome from the fertilisation to the 3-pronulcei 
phase, approximately 15 hours after, when DNMT1 expression is very low and DNA 
methylation is almost completely lost (Amouroux et al., 2016; von Meyenn et al., 2016).  
Active demethylation implies the process of methyl groups removal from the 
genome that occurs not concomitantly with DNA duplication. This active removal is 
operated by two main families of “erasers” in mammals: AID/APOBEC (activation-induced 
cytidine deaminase/apolipopotein B mRNA-editing enzyme complex) and Ten Eleven 
Translocation (TET) enzymes (Figure 1.4) (Moore et al., 2013). The first route is a 
deamination reaction of the amine to a carbonyl group, leading to the formation of a 
thymine and thus a mismatch. The first AID step is then followed by the correction of the 
mismatch by the Base Excision Repair (BER) pathway, through the activation of the 
thymidine DNA glycosylase (TDG). The second route is made possible by the activity of 
the TET enzymes. These is a family of 3 oxygenases (TET1, TET2, TET3), that use O2 to 
oxydise 5meC to 5 hydroxymethyl-cytosine (5hmeC) (Tahiliani et al., 2009). The 
subsequent reactions are further oxidations of 5hmeC to 5-formyl-cytosine (5fC) and 5-
carboxy-cytosine (5CaC), which is then finally removed by the intervention of the BER 
pathway, leading to the complete removal of the methyl group and the re-establishment of 
an unmodified cytosine. Alternatively, 5hmeC can be deaminated by AID to 5 
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hydroxymethyl-uracil (5hmeU) leading again to the activation of the BER pathway (Figure 
1.4).  
The discovery of these enzymes finally proved the existence of an active removal of 
the DNA methylation in metazoan species, including mammals, that was until then only 
hypothesised. However, there are still many open questions. For instance, the role of the 
TET enzymes during the early phases of development is yet controversial. In fact, while 
5hmeC was initially detected in the paternal genome, more recently mass spectrometry 
analyses have shown that rate of paternal 5hmeC does not change significantly in 
absence of TET3, suggesting that DNMT3A and DNMT1 might be accounted for the 
demethylation (Amouroux et al., 2016). Nevertheless, 5hmeC is now considered an 
epigenetic mark in its own right, but its biological meaning is yet to be fully uncovered. 
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Figure 1.4 Active DNA demethylation
Different routes for active DNA demethylation. 5meC can be deaminated by the AID/APOBEC complex (1) 
to Thymidine (T) and then the mismatch repaired by the BER pathway, by thymidine DNA glycosylase (TDG). 
Alternatevely, the 5meC can be oxydised by the Ten Eleven Translocation enzymes (TET) to 5hmeC (2), 
which can be either subsequently deaminated by the AID/APOBEC complex (2a) to 5hmU or further oxydised
by TET once to 5fC or twice to 5caC (2b). The mismatch is repaired by TDG in all cases, leading to the 





























































1.3. DNA methylation in early embryonic development 
 
1.3.1. Dynamics of DNA methylation in early embryonic development 
 
It has been long known that some traits can be inherited by the progeny, despite not 
being encoded in the genome. It is now better understood how some of these epigenetic 
modifications are passed onto the new generation and their importance in the correct 
formation of the embryo. These loci are imprinted genes (Ferguson-Smith, 2011). The 
term genomic imprinting describes a phenomenon by which a group of genes is 
monoallelically expressed, accordingly to the methylation status of the parent of origin. 
The DNA methylation of the differentially methylated regions (DMRs) of the parental 
genome regulates imprinting. However, not all DNA methylation is inherited from the 
parental genomes. In fact, this modification goes through heavy reprogramming in germ 
cells and then during the early phases of the development (Figure 1.5B) (Ambrosi et al., 
2017; Smith et al., 2012; Wang et al., 2014). 
The maternal and paternal gametes have a very well established and different DNA 
methylation profiles. More specifically, the paternal genome has higher methylation levels 
compared to the maternal genome (Figure 1.5B). Before the parental nuclei fuse, after 
fertilisation, a demethylation wave is started with the almost complete erasure of 5meC 
from the genome by the time the inner cell mass forms in the pre-implantation blastocyst. 
However, the depletion of 5meC occurs with different dynamics in the two fusing genomes 
(Ambrosi et al., 2017; Smith et al., 2012; Wang et al., 2014).  
The sperm genome undergoes a fast demethylation process (Ambrosi et al., 2017; 
Howlett & Reik, 1991), resulting in an almost complete loss of 5mC prior the beginning of 
the cell divisions. Studies have shown that the loss of methylation in sperm is active and 
most probably accomplished by the TET3 enzymes (Ambrosi et al., 2017; Iqbal et al., 
2011; Wossidlo et al., 2011). In fact, accumulation of 5hmeC was detected in the time 
frame between fertilisation and cell division. This supports the hypothesis that the 
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demethylation occurring is a consequence of the activity of the TET enzymes. 
Surprisingly, a recent study (Amouroux et al., 2016) showed that the demethylation of the 
paternal genome in the zygote is not affected by the loss of TET3, suggesting that other 
mechanisms might be crucial for this loss.  
On the other hand, the oocyte has a lower DNA methylation compared to sperm. 
However, loss of methylation is slower and the minimum is reached at the blastocyst stage 
(Ambrosi et al., 2017; Howlett & Reik, 1991). In this case, the loss is passive and 
concomitant with the cell divisions. Due to the difference in rate of loss, the methylation 
detected between the PN1 and PN2 phases of the embryonic development is to attribute 
mainly to the maternal genome. This pattern is then slowly lost by dilution.  
Some loci are excluded from this demethylation (Wang et al., 2014), such as 
differentially methylated imprinting control regions and some repetitive elements, such as 
Intercisternal A particles (IAPs). This indicates the existence of a maintenance mechanism 
that stop the demethylation from happening and therefore protects specifically these loci. 
Furthermore, this also suggests that DNA methylation might not be the only mark that 
suppresses the transcription of these elements. This was proven true for the IAP elements 
(Lane et al., 2003): DNMT1O, a shorter isoform of DNMT1, is the maintenance DNA 
methyltransferase responsible for protecting these loci in the early embryo. DNMT1O is 
maternally inherited and, despite DNMT1 being expressed at all stages of development, it 
is crucial for keeping these repetitive elements methylated. DNMT1s becomes important 
only later, after the blastocyst stage (Ambrosi et al., 2017). 
After embryonic day 3.5 (E3.5), the blastocyst starts developing into the epiblast and 
concomitantly with the implantation of the embryo, a de novo methylation wave starts 
(Figure 1.5B). The de novo methyltransferases are expressed and methyl groups are 
deposited onto the genome. Despite both de novo methyltransferase being expressed, it 
was shown that DNMT3B is the main responsible for the wave of methylation occurring at 
this stage (Ambrosi et al., 2017; Borgel et al., 2010). DNMT3a is more important in later 




1.3.2. Misregulation of DNA methylation in early development 
 
Due to the biological importance of DNA methylation, any dysfunction of the 
modification, of one of its readers, writers or erasers (Table 1), or of a chromatin 
remodeler, can lead to disease or even embryonic lethality, due to the severe 
misregulation of gene expression and consequently cell differentiation.   
These phenotypes can be linked to hypomethylation or hypermethylation of the 
genome. Overall, the consequences of the absence of DNA methylation are linked to 
changes in the conformation of chromatin. In fact, DNA methylation itself limits the 
accessibility of chromatin by making protein and transcription binding site not available 
(Keshet et al., 1986) and, by doing so, participates in the protection of the genome. 
Therefore, hypomethylation could be linked to open chromatin, increased accessibility and 
thereby affect genome stability and integrity (Meng et al., 2015).  
Knock outs of DNMT1 in mice lead to embryonic lethality by E9.5, whereas KOs in 
mESCs determine reduction of the global methylation level and has no effect on cell 
proliferation or viability (Li et al., 1992; Liao et al., 2015). This suggests that maintenance 
of DNA methylation does not only depend on DNMT1 but has probably redundant 
effectors, that can compensate for absence of DNMT1, when the cells do not go through 
reprogramming. Mutations in Dnmt1 in humans are also associated with cancer. Similarly, 
in mice mutations of DNMT3B can be either embryonic lethal or lead to growth retardation 
and hypomethylation at minor satellite DNA (Meng et al., 2015; Okano et al., 1999). In 
adult mice and humans, mutations in Dnmt3b are common in cancer (Zhang et al., 2017). 
Importantly, mutations of this de novo methyltransferase were found in patients affected 
by a rare autosomal recessive disease, the Immunodeficiency Centromeric Instability 
Facial Abnormalities Syndrome (ICF). Knock outs of Dnmt3a in mice are not embryonic 
lethal, indicating the importance of this protein later in embryonic development (Meng et 
al., 2015; Okano et al., 1999). However, these mice die shortly after birth. Finally, triple 
KOs of the DNMTs are embryonic lethal.  
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Experiments in mice have shown that both single and double KOs of Tet1 and Tet2 
are viable (Rasmussen & Helin, 2016). Single KOs showed specific phenotypes: while 
TET1 depletion leads to reduced litter size, lack of TET2 results in higher incidence of 
leukaemia (Ambrosi et al., 2017). Interestingly, Tet3 KO mice die shortly after birth. As 
TET3 is the main demethylase expresses at the very first stages of development (Figure 
1.5A), these results suggest that it might be the most developmentally important 
demethylase.  
Chromatin remodelling enzymes are crucial for providing methyl transferases with 
access to chromatin. When thinking of DNA methylation as a keeper of genome stability 
and integrity, chromatin remodelling enzymes could be considered crucial for maintaining 
genome stability. Therefore, any mutation or deletions of remodelers involved in DNA 
methylation subsequently impairs this mechanism. Mutations of chromatin remodelers 
were in fact found in many cancer types (Längst & Manelyte, 2015; Narlikar et al., 2013), 





1.4. Chromatin remodelling 
 
 
1.1.1. ATP dependent chromatin remodelers families  
 
Packaging of DNA into cell nuclei is essential for the survival of any organism. This 
is achieved because of a very well organized structure, the chromatin, whose unit is the 
nucleosome core. As discussed above, a nucleosome is composed by 147bp of DNA 
tightly wrapped 1 and three quarter turns around a histone octamer. Nucleosomes are 
then separated by a linker DNA, which has a variable length between 20 and 90 bp. This 
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structure is highly flexible and dynamic and has been thoroughly studied in the past 
decades by employing variety of approaches including new technologies that enabled 
whole genome nucleosome mapping. It has been shown that the positioning of the 
nucleosomes on the chromatin depends on DNA sequence and thus is determined by the 
chemical characteristics of the DNA (such as the preference for GC rich sequences over 
AT rich ones) (Blossey & Schiessel, 2018). However, the variability of nucleosome 
positioning in differentiating cells or during development suggests that the sequence 
cannot be the only regulation mechanism for the positioning of nucleosome.  
Importantly, in order for changes in positioning to occur, many hydrogens bonds 
between nucleosomes and DNA have to be disrupted. Enzymes responsible for this are 
the chromatin remodelers. These are typically DNA translocases that use ATP hydrolysis 
to rearrange nucleosomes on chromatin. Chromatin remodelers are very abundant. In fact, 
it has been estimated that there is about one remodelling complex per 10 nucleosomes in 
the nucleus (Erdel et al., 2011; Erdel & Rippe, 2011; Rippe et al., 2007). 
All the members of this class of enzymes are characterised structurally by the 
presence of a catalytic ATPase domain of the Snf2 subfamily, consisting of a DExx and a 
Helicase C domains (Figure 1.6) (Längst & Manelyte, 2015), a superfamily of proteins. 
Furthermore, there is a large variety of proteins and protein complexes classified as 
chromatin remodelers, all characterised by some basic properties: affinity for DNA and 
nucleosomes, reader domain for binding to epigenetic modifications, domains regulating 
the ATPase activity and domains for the interaction with other proteins (Clapier & Cairns, 
2009). These conserved domains are accompanied by unique domains, such as the 
Bromo or Chromo domains, that are the “reader” domains of the protein, capable of 
recognising epigenetic marks and determining the recruitment of the remodeler onto the 
chromatin. Based on the sequence similarity of the proteins, 4 conserved families have 
been classified: SWI/SNF, CHD, ISWI, INO80 (Figure 1.6).  
The SWI/SNF (switching defective/sucrose nonfermenting) family was the first to be 
identified in yeast and is characterised by the presence of a C-terminal Bromo domain, 
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that recognises acetylated lysines in histone tails. Furthermore, an HSA (Helicase SANT) 
N terminal domain is present and is predicted to bind DNA. Two main complexes belong 
to this family, in human BAF and PBAF, organized around the BRG1 and BRM subunits.  
The CHD (chromodomain, helicase, DNA binding) family has a characteristic N 
terminal domain, containing two tandem Chromo domains, responsible for the binding to 
methylated lysines at histone tails. It could be further divided into subfamilies, based on 
other structural domains (Clapier & Cairns, 2009; Längst & Manelyte, 2015). The main 
complex in mammalian cells is NuRD (nucleosome remodelling and deacetylase), a large 
remodelling complex containing a number of auxiliary proteins including histone 
deacetylases HDAC1 and HDAC2 and MBD3, a member of methyl CpG-binding domain 
protein family.  
The ISWI (imitation switch) family is characterised by a SANT and a SLIDE domain, 
adjacent to each other on the C-terminal of the protein. It contains 2 to 4 subunits and 
forms the human NURF, CHRAC and ACF complexes. 
The INO80 (inositol requiring 80) family is peculiar for the presence of an insertion, 
forming a split ATPase domain. This insertion is required for the binding of a helicase-




Figure 1.6 Chromatin remodellers.
Simplified representation of the domain organisation for the main families of chromatin remodeling ATPases. 
The HelicaseC and the DEXX domains are shared between all the classes. Some domains are specific for 
each class. The Bromo domain recognises acetylated lysines and is characteristic of the SWI/SNF family. 
Methylated lysines recognition is assured by the Chromo domain in the CHD family. HAND, SANT and 
SLIDE can recognise nucleosomes and DNA, and are characteristic of the ISWI family. Finally, the HSA 






















SNF2 family ATPase region
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1.1.2. Function of chromatin remodelers 
 
As briefly described above, the chromatin remodelling family of enzymes comprise a 
large variety of remodelling complexes and proteins. Despite having different specific 
roles, it is correct to say that these enzymes are responsible for modifying the state of the 
chromatin. The perturbation of the chromatin state is mainly aimed to expose a hidden site 
on the DNA or alter the composition of chromatin itself. To expose an underlying 
sequence of DNA, nucleosomes can either slide and thereby be repositioned to a 
neighbouring DNA, or evicted from the chromatin. Alternatively, unwrapping of the DNA 
around the histone octamer can expose a shorter sequence or allow inclusion of a new 
nucleosome (Maier et al., 2008; Morrison & Shen, 2009). Remodelers are also capable of 
modifying the composition of the chromatin by exchange of histone variants, such as the 
H3.3 at telomeres or ejection of a dimer (Clapier & Cairns, 2009; Längst & Manelyte, 
2015).   
Despite being difficult to classify the remodelers depending on their activity, it is 
possible to distinguish them depending on the presence of specific domains (Clapier & 
Cairns, 2009; Längst & Manelyte, 2015). In fact, SWI/SNF are mainly responsible for 
sliding and eviction of nucleosomes from the DNA, lacking any assembly properties. On 
the other hand, the NuRD complex (CHD family) is important for repression of 
transcription, whereas other complexes of the family are reported to be responsible for 
sliding of the nucleosome to promote transcription. Most of the ISWI complexes catalyse 
nucleosome spacing, compaction and formation of higher order structures, concomitantly 
with repression of the DNA sequence. Finally, the INO80 family is the only one showing 
helicase activity and INO80 and SWR1 were shown to be responsible for removing H2A-
H2B dimers and replacing with the histone variants H2A.Z-H2B.  
The existence of many remodelling complexes and the specificity of these proteins 
for any DNA suggest the existence of a more complex regulatory mechanism, resulting 
from the interplay of the DNA sequence, the context the DNA sequence is in, the 
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epigenetic marks occurring on the histones and, nevertheless, the specificity of the single 
remodeler. Not surprisingly, in fact, a study comparing NURD, (P)BAP, INO80 and ISWI 
genome-wide showed that each enzyme has a unique set of targets (Moshkin et al., 
2012). We are yet far from fully understand how this specificity is determined and how the 
remodelers are capable of complementing each other’s work to maintain genome stability 
and integrity.  
An exception to these canonical remodelers is the protein LSH. Despite being 
classified as a member of the Sfn2-like group of remodelers, its chromatin remodeler 
activity in complex with CDC7A has only been recently proven (Jenness et al., 2018). 
Interestingly, however, it was shown to be crucial for normal levels and patterns of DNA 




1.5. Lymphoid Specific Helicase (LSH) 
 
1.1.3. LSH, characteristics and structure   
 
LSH, also known as HELLS, PASG and SMARCA6, is an ATP-dependent chromatin 
remodeler, member of the SNF2 superfamily of remodelers is DDM1 (decrease in DNA 
methylation 1), the plant homologue of mammalian LSH, was identified first (Vongs et al., 
1993). In a screening in Arabidopsis thaliana aimed to identify mutants causing genome 
hypomethylation, deficiency in DDM1 in the plant was shown to cause 70% loss of DNA 
methylation (Vongs et al., 1993).  
Due to its sequence similarity with the SNF2 remodelers (Figure 1.7), DDM1 was 
hypothesized to be a novel chromatin remodeler and its remodelling activity was 
demonstrated in a later study (Brzeski & Jerzmanowski, 2003; Jeddeloh et al., 1999).  
The mammalian LSH was identified later, firstly in activated lymphocytes (Jarvis et 
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al., 1996). In that study, LSH was discovered while looking for a helicase responsible for 
the somatic recombination of the VJ locus, thereby the descriptive name given. However, 
the helicase activity of LSH has never demonstrated. It was then found in mouse thymus 
and testis and shown to be highly expressed in all dividing cells in the mouse embryo 
(Raabe et al., 2001). It is now well known that LSH is expressed in the adult mice as well.  
In mouse, the Lsh gene is located on chromosome 19 and contains 24 exons. The 
gene is transcribed into an 821 amino acids protein. The amino acid sequence is well 
conserved between species and differs between mouse and humans for 16 additional 
amino acids at the N-terminus of the human protein (Briones & Muegge, 2012). A coiled-
coil motif characterises the N-terminus of the protein, which contains the nuclear 
localisation signal (NLS) (Figure 1.7). The catalytic ATPase domain is organised as two 
lobes, both containing an ATP binding sequence, and contains 7 helicase motifs, 
characteristics of this superfamily of remodelers. The first lobe is characterised by a 
DeXX, or SNF2_N, motif and the second by an HELIC_C motif (Figure 1.7). 
Most of the chromatin remodelling proteins form big protein complexes. On the 
contrary, it was shown that LSH is mainly found as a monomer (Myant & Stancheva, 
2008). Interestingly, it is indeed capable of binding other proteins. More specifically, pull-
downs experiments have proven a direct interaction between LSH and DNMT3B, via the 
CoiledCoil N-terminal domain of LSH (Myant & Stancheva, 2008). This interaction seems 
to work as a bridge for the recruitment of DNMT1, that can finally recruit the HDAC1 and 
HDAC2. These enzymes remove acetyl groups form lysines, allowing compaction of 
chromatin and therefore transcriptional repression of the region. Furthermore, the coiled-
coil motif binds the E2F3 transcription factor, cooperating with its role in tumour 
progression (Von Eyss et al., 2012). More recently, it was shown that LSH and the zinc 
finger protein CDCA7 form a chromatin remodelling complex (Jenness et al., 2018). 
Altogether, these findings highlight that LSH requires other proteins, part of its 





1.1.4. Function of LSH, from plants to mammals  
 
In plants, DDM1 was shown to reposition nucleosomes in vitro and its absence in 
Arabidopsis leads to hypomethylation at CpG and CpNpG sites, together with 
misexpression of retrotransposons, that disrupts expression of protein coding genes 
(Brzeski & Jerzmanowski, 2003; Vongs et al., 1993). Knock-outs in plants are 
characterised by a rearrangement of histone modifications, more specifically by the 
replacement of H3K9me2/3 by H3K4me, as a sign of euchromatin formation and 
eventually activation of gene expression. Moreover, defects in mitosis and in DNA damage 
response and morphological abnormalities in leaves shape and number have been 
described in ddm1 mutant A.thaliana (Jeddeloh et al., 1999; Kakutani et al., 1995). 
Despite having been named in mammals Lymphoid specific helicase, it has been 
ruled out any helicase activity of the protein. However, it was shown necessary for DNA 
methylation throughout the genome in mammals as well (Dennis, 2001; Zhu et al., 2006). 
Figure 1.7 Domain organisation of chromatin remodeling ATPase LSH.
Schematic representation of the domain organisation of murine LSH. The N-terminal domain of the 
protein includes a Coiled-Coil (CC) motif (yellow), required for interactions with DNMT3B and recruitment 
of HDACs, and the nuclear localisation signal (NLS - green). The catalytic ATPase domain includes DeXX, or 
SNF2_N (red) and helicase motifs (black and grey), and Helicase C (green) and helicase motifs (black 
and grey).The two ATP binding sites (grey) bind ATP simultaneously.
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In fact, depletion of LSH in mouse leads to up to 50% loss of 5meC on a whole genome 
level. The hypomethylation is accompanied by rearrangement of histone modification. 
More specifically, increase in acetylation at H3 and H4 and local increased of H3K4ac 
were detected in LSH depleted cells (Dennis et al., 2001; Tao et al., 2011; Termanis et al., 
2016). Studies have shown that cells lacking LSH show hypomethylation at both repetitive 
and non-repetitive sequences. Many studies have analysed methylation of specific loci in 
the genome and identified few that require LSH for correct methylation. More specifically, 
Yu and colleagues showed that the knockout (KO) of Lsh causes hypomethylation of long 
terminal repeats (LTR) of many retrotransposons, including satellites sequences, 
endogenous retroviral elements (ERVs) and IAPs. The hypomethylation leads to 
expression of these elements, thereby highlighting a role of LSH in protecting genome 
integrity (Huang et al., 2004; Yu et al., 2014a). Furthermore, a 2007 study showed that 
Lsh knockout induces expression of HoxA6 and HoxA7 genes, possibly because LSH is 
required at these loci to regulate DNMT3B binding and silencing of gene expression (Xi et 
al., 2007). However, misexpression of Hox genes is known for leading to homeotic defects 
and specifically HoxA6 and HoxA7 are involved in hematopoietic and ovarian epithelial cell 
cancers, defects that have not been detected in Lsh-/- mice. This suggests that the defects 
found in Lsh-/- MEFs in this study might be reversible and overcome in vivo during 
differentiation. More studies have shown importance of LSH in methylation of specific 
genes, such as the Rhox cluster (Donohoe et al., 2009; Fan, 2005; Myant et al., 2011; 
Ren et al., 2017). Furthermore, it was shown that reintroduction of a catalytically active 
LSH protein in KO MEFs can partially recover the loss of DNA methylation and determine 
re-silencing of misexpressed genes (Termanis et al., 2016). However, no whole genome 
analysis has been performed in the early development mouse, to determine all the loci in 
the genome that require LSH for correct methylation and thereby are found 
hypomethylated.  
An interesting debate is whether LSH is required for de novo DNA methylation or 
maintenance, or maybe for both these processes. Transfection of an unmodified episomal 
DNA in Lsh-/- mouse embryonic fibroblasts (MEFs) was used to prove the role of LSH in 
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vitro in de novo methylation, but not maintenance (Lungu et al., 2015; Zhu et al., 2006). 
However, several studies have been published supporting the importance of LSH in DNA 
methylation maintenance, for instance in cancer (Dennis et al., 2001; Samuelsson et al., 
2016) or specifically at repetitive elements in mice (Suzuki et al., 2008).  
Similarly to DDM1, LSH depletion has an effect on histone modifications. More 
specifically, it determines perturbation of H3K4me3 and increase in acetylation of the 
histone tails (Yan et al., 2003). This correlates with the loss of DNA methylation and 
therefore of heterochromatin. Furthermore, pull downs experiments proving the co-
immunoprecipitation of LSH and DNMT3B (Myant & Stancheva, 2008) suggested that the 
activity of LSH might be linked to that of the de novo methyltransferase. It is proposed that 
LSH recruits DNMT3B and determines an increase of its concentration locally, supporting 
the methyl transferase activity of the protein. However, it is important to highlight that LSH 
activity is not exclusively associated with DNMT3B. In fact, several studies have shown 
that LSH has a role independent of the methyl transferase in methylation of repetitive 
elements, in association with G9a/GLP HMT, but also in cancer progression (Dunican et 
al., 2013; X. He et al., 2016; Jiang et al., 2017; Joshi et al., 2011; Myant et al., 2011). 
Despite the ATP-dependent chromatin remodelling activity of LSH being considered 
the main function of the protein (Ren et al., 2015), the most evolutionary conserved 
function of LSH is in DNA repair. Previous studies in budding yeast (Alvaro et al., 2007; 
Costanzo et al., 2010), which have no DNA methylation, but carry an LSH homologue, and 
in A.thaliana (Costanzo et al., 2010; Shaked et al., 2006) have proposed a role of LSH 
independent of its DNA methylation activity. A subsequent study in human fibroblasts and 
mouse showed that Lsh-/- cells are more sensitive to ionizing radiation (IR) and repair 
double strand breaks (DSB) less efficiently (Burrage et al., 2012). This impairment is 
mainly due to less stable and permanent phosphorylation of the H2AX histone variant in 
response to IR, which impairs the recruitment of the DSB repair machinery, finally 
determining absence of phosphorylation of the checkpoint CHK2 protein. In addition, the 
study proved that the catalytic activity of LSH is responsible for its role in DNA damage 
repair. Altogether these data showed that LSH can have a role independent of its activity 
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in DNA methylation, but it remains unclear how this could be linked to its role as a 
chromatin remodeler.  
 
 
1.1.5. Characterisation of LSH Knockouts in mouse 
 
To understand LSH function, generation of LSH-null cell lines and knockout mouse 
was necessary. Currently, there are two mouse models published in literature, carrying 
this deletion.  
The first Lsh-/- mouse was generated by targeted deletion of exons 6 and 7 via 
homologous recombination (Geiman et al., 2001). Helicase domain I and II were replaced 
by a cassette containing neomycin resistance (neo) and thereby premature perturbation of 
transcription and translation prevented production of full length protein. Heterozygous 
mice for the deletion looked indistinguishable from their wild type littermates. However, the 
Lsh-/- mice, despite surviving through development, die few hours after birth. Only one out 
of 480 mice survived up to 5 days postnatally. Moreover, these mice showed 22% 
reduction in weight compared to the littermates and severe kidney failure. Studies 
performed on these mice, showed instability of the mitotic spindle and reduced 
proliferation (Tao Fan et al., 2003) and accumulation of H3K4 methylation (Yan et al., 
2003). Due to the short survival time, no further conclusions could be drawn.  
Subsequently, Sun and others generated a different KO mice, by replacing exons 
10, 11 and 12, together with helicase domain II, III and IV, with a neo cassette (Sun et al., 
2004). These deletions resulted in the production of an hypomorphic mutation. Once 
again, the heterozygous mice looked phenotypically similar to the wild type littermates and 
no hypomethylation was detected on a whole genome level. This approach resulted in 
higher percentage of survival after birth. However, only 40% of Lsh-/- mice survived up to 
few weeks postnatally. Nevertheless, the mice were severely affected by the absence of 
LSH. More specifically, they showed 25% weigh reduction at birth comparted to the wild 
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type littermates, growth retardation and a severe aging phenotype, manifested by hair 
loss, cachexia and reduced fat accumulation. Moreover, these mice exhibited lymphoid 
depletion, respiratory and kidney failure, osteoporosis and osteopenia. Analyses of Lsh-/-  
MEFs isolated from this strain showed increased expression of senescence-associated 
genes. Altogether, these data suggest the importance of LSH during early phases of 
development, despite not determining the exact time-frame of activity of the chromatin 
remodeler.   
Recently, in the Stancheva lab, a new mouse model was generated (unpublished 
data, Chao Li). This new strain carries a conditionally reversible stop cassette inserted into 
intron 3 of the Lsh gene (Figure 1.8). This cassette contains a splicing acceptor (SA), a 
EGFP-neomycin resistance gene followed by a polyadenylation site at the 3’ end. This 
cassette is flanked by inverted LoxP and Frt sites, that can be used to conditionally flip the 
cassette orientation and thereby re-establish normal expression of the locus. The cassette 
was integrated either into one or into both alleles in ES cells to produce lines with Lshoff/+ 
or Lshoff/off genotype. The Lshoff/+ or Lshoff/off ESC cell lines were further used for in vitro 
experiments. Protein expression analysis showed that LSH proteins was undetectable 
both in Lshoff/off ESCs and E12.5 embryos, compared to the heterozygous control without 
affecting the expression of the DNMTs (unpublished data – Chao Li). Mice generated from 
Lshoff/+ ESCs develop and survive postnatally for up to 16 weeks. Nevertheless, they 
experience severe weight loss and develop neurological problems shortly after birth. 
Furthermore, these mice show DNA methylation loss comparable to previously generated 
Lshoff/off mice, including hypomethylation of centromeric repeats, IAPs and unique loci 
(unpublished data – Chao Li). Altogether, these experiments validate the mouse knockout 
generated in the Stancheva lab. The Lshoff/off mice generated in the lab constitute a great 
model to study in vivo the consequences of LSH deficiency after birth: they are efficiently 
depleted of LSH, and, compared to the other KOs mice, they also carry fewer 





For this work, we used Lshoff/+ or Lshoff/off ESC cells, that were not derived from 
mouse blastocysts, but were produced by homologous recombination from wild type 
ESCs. These cells provided a big advantage for the study of changes occurring during 
reprogramming events. In fact, DNA hypomethylation at unique and repetitive sequences, 
such as IAPs, occurs in absence of LSH during embryonic development and more 
specifically between E6.5 and E9.5. Since the Lshoff/+ or Lshoff/off ESC we used in this study 
had not gone through embryonic development and reprogramming, it was possible to 
analyse the effects of LSH on DNA methylation maintenance and establishment, in the 
absence of developmental reprogramming that occurs early in mammalian development. 
Then, by inducing reprogramming of the DNA methylation, we could study how absence of 
LSH interferes in time in de novo and maintenance of DNA methylation and in 
differentiation. 
 
Figure 1.8 Domain organisation of the knock-out cassette.
Representation of the cassette introduced in the Lsh locus to produce the off allele. The off cassette
was introduced in intron 3 by homologous recombination. Black boxes represents exons, SA = splicing 
acceptor; pA = polyadenylation site; coloured triangles represent (in order) LoxP, lox511, Frt and F3 sites 












Authors Knock-out Protein mutation Phenotype 
Geiman et al., 2001 Deletion of exons 6 and 
7, via homologous 
recombination; 
replacement of helicase 
domain I and II by a neo 
resistance cassette.  
Prevention of 





wild type littermates. 
Lsh-/- mice: 1 out of 480 
mice survived more than 
few hours after birth. 
Mitotic spindle 
instability and reduced 
cell proliferation (Fan et 
al., 2003), accumulation 
of H3K4me (Yan et al., 
2003). 
Sun et al., 2004 Replacement of exons 
10, 11, 12 and 
replacement of helicase 
domain II, III, IV with a 





wild type littermates. 
Lsh-/- mice: 40% of mice 
survived few weeks after 
birth; weight reduction at 
birth, growth retardation 
and aging phenotype. 
Chao Li 
(unpublished) 
Insertion of a 
conditionally reversible 
stop cassette in intron 3. 





wild type littermates. 
Lshoff/off mice: survive 
postnatally for up to 16 
weeks; weight loss and 
neurological problems.  
 
 
1.1.6. LSH misregulation and disease 
 
DNA methylation is crucial to assure stability and integrity of the genome, thereby 
allowing normal function of the cell and, eventually of the whole organism. When removing 
LSH, mice cannot survive after birth, showing severe phenotypes, or, when surviving, 
Appendix Table 1.BioCAP-sequencing quality control. 
In the first column, samples sequenced are listed: HT = Lshoff/+ KO = Lshoff/off .
In the second column, the percentage of duplicates is indicated.
In the third column, the percentage of GC in each sample is indicated. 
In the fourth column, the milion of reads sequenced per each sample is indicated.  
Table 1.Control of DNA methylation. 
Brief summary of the main proteins that participate into DNA methylation control, as
writers, readers or erasers. In the last column, references of main works on the proteins
and figures in this thesis work.
Table 3.LSH knock-outs. 
Brief summary of the main knock-outs models for LSH in mice. The first works regarding the 
mouse model are listed in the first column. The approaches used to produce the KOs are
indicated in the second and third columns. In the last column a brief description of the 
phenotipe of the mouse model is reported. 
Table 2.DNA methylation in different living organisms. 
Brief summary of the characteristics of DNA methylation in different groups of eukaryots.
5meC patterns are very variable among different species, therefore in the last column 
some species are listed as examples of exceptions to the characteristics of their group.
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eventually develop disease. This suggest the importance of the protein for the 
development of the organism and the need for better understanding its role and mode of 
action.  
Interestingly, not only depletion, but also mutations or overexpression of LSH were 
linked to disease, such as ICF, leukaemia and glioma (He et al., 2016; Jenness et al., 
2018; Joshi et al., 2011; Keyes et al., 2011; Thijssen et al., 2015; Velasco et al., 2018; 
Xiao et al., 2017). These mutations are generally determinants of hypomethylation and 
subsequently misexpression of protein coding genes and repetitive elements, which plays 
an important role in determining the pathological phenotype.  
An important example of disease linked to hypomethylation is the ICF syndrome. 
This is a rare recessive autosomal disorder characterised by severe immunodeficiency, 
which make patients affected more susceptible to infections of the respiratory and 
gastrointestinal tract, associated in most cases with facial abnormalities. One of the 
hallmarks of ICF is the hypomethylation of Centromeric regions, leading to instable and 
fragile chromosomes 1, 9 and 16 (Hulten, 1978). Only around 50% of patients affected by 
ICF syndrome are characterised by mutations in the methyl transferases and less than 
30% in ZBTB24. In more recent years, mutations associated to this syndrome have been 
identified in CDCA7 and LSH/HELLS genes (Thijssen et al., 2015). This led to the 
characterizations of subgroups of patients, namely ICF1 (mutations in DNMT3B), ICF2 
(mutations in ZBTB24), ICF3 (mutations in CDCA7) and ICF4 (mutations in LSH/HELLS). 
Importantly, Velasco and colleagues have shown that the hypomethylated sequences in 
ICF2,3,4 patients are different from the hypomethylated regions of patients with ICF1 
(Velasco et al., 2018). This further supports the hypothesis of a partially separate role of 
LSH from DNMT3B, with LSH supporting DNMT3B for methylating only some genomic 
regions. Recently, the Funabiki lab has shown that CDCA7 and LSH work together as a 
remodelling complex (Jenness et al., 2018). In this work, they showed that CDCA7 
facilitated LSH binding to chromatin and stimulates LSH remodelling activity, 
independently of its DNA-binding activity. Despite not been able to fully characterize the 
process, they showed the importance of the formation of this complex. Furthermore, they 
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suggest that mutations in the complex in ICF patients are most likely responsible for 
inability of recruitment of LSH to chromatin and therefore impossibility to methylate the 
DNA. However, further molecular studies are necessary to elucidate the mechanisms 
behind this disorder.  
 
 
1.6. Open questions and aims of the project 
 
In this brief introduction on chromatin modifications, modifiers and LSH, I tried to 
show the importance of epigenetic mechanisms for development and normal functions of 
cells. There are still many questions to be answered. In the Stancheva lab, we focused our 
attention on the chromatin remodeler LSH. Despite many studies of this protein have 
shown its importance in DNA methylation and involvement in other cell pathways, such as 
DNA repair, there is still a lot to clarify. The focus of my work was to address the following 
questions:  
• Does the lack of LSH impair the establishment or the maintenance of DNA 
methylation? When is LSH required during mammalian development? 
• Is DNA methylation at specific loci LSH dependent? If so, which loci require LSH 
activity? 
• How does the absence of LSH lead to hypomethylation of the genome? 
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2.1.1. DNA analysis buffers 
 
Tris-EDTA (TE) buffer: 10 mM Tris-HCl pH 7.5, 1 mM EDTA pH 8.0 
Tris-buffered saline (TBS): 50 mM Tris-HCl pH 8.0, 150 mM NaCl  
SSC buffer: 175.3 g NaCl2, 88.2 g Na3C6H5O7 were used for 1 L of solution. pH was 
adjusted to pH 7 with HCl. 
Denaturing buffer: 1M NaOH, 0.5 EDTA 
Orange G loading buffer (6X): 10 mM Tris-HCl (pH 7.6), 0.15% orange G, 60% glycerol 
and 60 mM EDTA.  
PCR buffer IV (10X): 200 mM (NH4)2SO4, 750 mM (Tris-HCl pH 8.8), 0.1% (v/v) Tween® 
20, 15 mM MgCl2.  
Special PCR buffer: 166 mM (NH4)2SO4, 670 mM Tris pH 8.0 and 100 mM ß-
mercaptoethanol. 
Sodium Acetate (3M): 40.8g of sodium acetate in 80ml of H2O. pH was adjust to 5.2 with 
acetic acid.  
Sequencing buffer (2.5X): 20 mM Tris-HCl pH 8.0 and 5 mM MgCl2. 






2.1.2. Protein analysis buffers 
 
Nuclear extraction buffer (NE1): 20mM HEPES pH7.5, 10mM KCl, 5mM MgCl2, 0.1% 
(v/v) Triton X-100, 20% (v/v) glycerol, 0.5mM DTT and Protease Inhibitor Cocktail (1X) 
(SIGMA-P8340), added prior to use.  
Sample buffer (4X): 200 mM Tris-HCL pH 6.8, 8% SDS, 20% Glycerol, bromophenol blue. 
DTT concentration was adjusted to 100 mM prior to use.  
SDS PAGE resolving gel: 7-20% (w/v) 29:1 acrylamide:bis-acrylamide, 0.1% (w/v) SDS, 
375 mM Tris-HCl pH 8.8, 0.1% (v/v) TEMED, 0.1% (w/v) APS.  
SDS PAGE stacking gel: 4% (w/v) 29:1 acrylamide:bis-acrylamide, 0.1% (w/v) SDS, 125 
mM Tris-HCl pH 6.8, 0.1% (v/v) TEMED, 0.1% (w/v) APS.  
Running buffer for Western blotting: 25 mM Tris, 250 mM Glycine and 0.1 % (w/v) SDS. 
Transfer buffer for Western blotting: 25 mM Tris and 250 mM Glycine.  
Ponceau S staining solution: 1% (v/v) glacial acetic acid, 0.5% (w/v) Ponceau S.  
 
 
2.1.3. HIS6-CxxC-AVI protein production  
 
Lysis Buffer: 50 mM Tris pH 8.0, 300 mM NaCl. 1 mM PMSF, 1/2 tablet Roche protease 
inhibitor cocktail and 10U/ml benzonase (12 μl) were added prior to the use. 
Ni-NTA Binding Buffer: 50 mM Tris pH 8.0, 300 mM NaCl and 1 mM Imidazole. 
Ni-NTA Low Salt Wash Buffer: 50 mM Tris pH 8.0, 300 mM NaCl, 10 mM Imidazole, 
0.1% Triton-X100. 1 mM PMSF was added prior to the use. 
Ni-NTA High Salt Wash Buffer: 50 mM Tris pH 8.0, 1M NaCl. 1 mM PMSF was added 
prior to the use. 
Ni-NTA Elution Buffer: 50 mM Tris pH 8.0, 300 mM NaCl, 300 mM Imidazole. 1 mM 
PMSF was added prior to the use. 
Dialysis Buffer: 50 mM Tris pH 8.0, 300 mM NaCl 0.5 mM PMSF was added prior to the 
use. 
Biotinylation Buffer: 20 mM Tris pH 8.0 and 250 mM Potassium glutamate. 
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Biomix (5X): 50 mM ATP, 50 mM MgOAc and 250 mM D-biotin. 
BC150: 20 mM HEPES pH 7.9, 150 mM KCl, 0.5 mM DTT and 10% v/v glycerol. 
 
 
2.1.4. Biotinilated CxxC affinity purification (BioCAP) 
sequencing buffers 
 
CAP100 Buffer: 100 mM NaCl, 0.1% Triton X-100, 20 mM HEPES-KOH pH 7.9 and 12.5% 
Glycerol. 
CAP300 Buffer: 300 mM NaCl, 0.1% Triton X-100, 20 mM HEPES-KOH pH 7.9 and 12.5% 
Glycerol. 
CAP500 Buffer: 500 mM NaCl, 0.1% Triton X-100, 20 mM HEPES-KOH pH 7.9 and 12.5% 
Glycerol. 
CAP700 Buffer: 700 mM NaCl, 0.1% Triton X-100, 20 mM HEPES-KOH pH 7.9 and 12.5% 
Glycerol. 






The antibodies used in this thesis work were the following: 
Antibody anti Species Use Producer 
DNMT3A Mouse Western Blotting Abcam 
DNMT3B Rabbit Western Blotting ThermoFisher 
DNMT1 Rabbit Western Blotting Santa Cruz 
LSH Mouse Western Blotting Santa Cruz 
HDAC1 Rabbit Western Blotting Santa Cruz 
Secondary ab Mouse or Rabbit Western Blotting LI-COR Biosciences 
5meC Mouse Dot Blot Active Motif 






The DNASTAR Lasergene software was used for primer designing. These were then 
purchased from Eurofins. The lyophilised primers were then diluted with ddH2O for 
stocking to 100 µM and stored at -20°C.  
The primers used in this thesis work were the following:  
 
PCR 
Primers for BioCAP-PCR analyses span CG rich promoter regions of the genes. Alignment 
maps are included in chapter 7. Appendix 
Fabp7 5’ - ATTGGCTTTTTGCCCGCTTC - 3’ 
5’ - AACTGGAGGAACTCGGGTCT - 3’ 
Msn 5’ - GGGGTTTGTAAAGTCGTGGC - 3’  
5’ - TTTGGCTGGAAACTGTCGGG - 3’ 
ActinB 5’ - AAGTGGCCTTGGAGTGTG - 3’ 
5’ - CAAGGAGTGCAAGAACACAGC - 3’ 
 
qRT-PCR  
Primers for qRTP-PCR analyses span exon-exon junctions. Alignment maps are included 
in chapter 7. Appendix  
GAPDH 5’ - TGGTATCGTGGAAGGACTCATGAC - 3’ 
5’ - ATGCCAGTGAGCTTCCCGTTCAGC - 3’ 
IAPs 5’ - ACTAACTCCTGCTGACTGG - 3’ 
5’ - TGTGGCTTGCTCATAGATTAG - 3’ 
DNMT3A 5’ - ACGGCAGAATAGCCAAGTTCA - 3’ 
5’ - TCAGTGCACCACAGGATGTC - 3’ 
DNMT3B 5’ - TGTGCCAGACCTTGGAAACC - 3’                       
5’ - TGTCTCCCTTCATTGTTTCCTGA - 3’ 
G9A 5’ - AGTGTAACCAGGCATGCTCC - 3’ 
5’ - TGCAGTAAACCTCGCCATCC - 3’ 
PRDM14 5’ - AAGCACCTGAAGTACACGCC - 3’ 







Primers for Bisulfite-PCR analysis span 5’UTR of IAP elements.  
IAPs (5’ UTR) 5’ - TTGATAGTTGTGTTTTAAGTGGTAAATAAA - 3’ 
5’ - AAAACACCACAAACCAAAATCTTCTAC - 3’ 
IAPs nested 5’ - TTGTGTTTTAAGTGGTAAATAAATAATTTG - 3’ 




Primers for Bisulfite-converted DNA sequencing analysis align to the commercially 
available cloning vector. 
pJET Seq-pJET-F 5’ - GCCTGAACACCATATCCATCC - 3’ 
 
IAPs nested 5’ - TTGTGTTTTAAGTGGTAAATAAATAATTTG - 3’ 








2.2.1. CELL CULTURE  
 
 
2.2.1.1. Embryonic stem cells 
 
Lshoff/+ and Lshoff/off ESCs were cultured either in serum-medium or 2i-medium. The 
formulations were as follow: 
• Serum medium: Minimum Essential Media with high glucose, 10% v/v Fetal 
Bovine Serum (Sigma), 0.1 mM nonessential aminoacids (Thermo Fisher 
Scientific), 1 mM sodium pyruvate (Thermo Fisher Scientific), 1µM β-
mercaptoethanol (Thermo Fisher Scientific), 1% v/v Penicillin-Streptomycin-
Glutamine (Thermo Fisher Scientific) and homemade LIF;  
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• 2i medium: Neurobasal media (Gibco), DMEM/F12 medium (Gibco), 0.5X N2 
supplement, 0.5X B27 supplement, 7.5% BSA (Sigma), 1% v/v Penicillin-
Streptomycin-Glutamine (Thermo Fisher Scientific), 1mM PD0325901 
(System Biosciences), 3mM CHIR99021 (System Biosciences), 1.5X 10-4M 
monothioglycerol and homemade LIF.  
For the facultative heterochromatin depletion experiment, Lshoff/+ and Lshoff/off ESCs 
were maintained in the same media stated above, with the addition of UNC0638 (Sigma, 
U4885) at 500 nM final concentration. The drug was added at every time the medium was 
changed or cell were passaged. 
When grown in serum medium, cells were grown on plates or flasks, coated with 
0.1% gelatine and maintained at 85%-90% confluency. Every other day, cells were either 
harvested or passaged, as follow: after washing the cells with warm 1X PBS, cells were 
detached with 0.1% warm trypsin (Thermo Fisher Scientific); trypsin was then inactivated 
with medium and seeded in a new plate or flask. When not passaged, or harvested, the 
medium of the cells was changed. The same protocol was applied when cells were treated 
with UNC0638.   
When grown in 2i medium, cells were grown on plates or flasks, coated with 0.1% 
gelatine and maintained at 85%-90% confluency. Every other day, cells were either 
harvested or passaged, as follow: after washing with warm 1X PBS, cells were detached 
with 1X TrypLE Express (Gibco); the enzyme was deactivated with BSA and the cell 
suspension was transferred to a sterile tube for centrifugation; finally, the supernatant was 
discarded and the cell pellet was resuspended in warm medium, to then be seeded to a 
new plate or flask. When not passaged or harvested, the medium of the cells was 
changed.  
Following harvesting of the cells, these were resuspended in 2ml of 1X PBS and 
centrifuged in a table top centrifuge. The supernatant was then removed and the cell 
pellets were either temporary stored at -70ºC or processed immediately. 
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2.2.1.2. Embryonic bodies 
 
Differentiation of ESCs into EBs was done as follow: ESCs were harvested and 
counted; 4*106 cells were then seeded in Petri dishes in a volume of 14 ml of serum 
medium, without LIF. At day 4, the medium was changed and replaced with EBs medium, 
with N2 supplement. At day 6, the medium was changed and replaced with EBs medium 
with N2 and retinoic acid. 
After 2 days, ESCs were already forming EBs and the medium was changed by 
transferring the cells suspension to a sterile tube and waiting until the cells settled at the 
bottom of the tube; the medium was then removed using a 3 ml sterile Pasteur pipette and 
cells were washed with 1X PBS. The PBS was removed after the cells settled once again 
at the bottom of the tube and replaced by 14 ml of warm medium. The same procedure 
was followed at day 4 and 6 of culture.  
At day 4 and 8, collection of the EBs was necessary: these were resuspended in 2 
ml of 1X PBS and centrifuged in table top centrifuge. The supernatant was then removed 
and the cell pellets were either temporary stored at -70ºC or processed immediately.   
 
 
2.2.1.3. Bacterial cells 
 
Bacterial cells used (E.coli DH5α) were grown in Liquid Lysogeny Broth (LB) 









2.2.2. NUCLEIC ACIDS ANALYSIS 
  
 
2.2.2.1. Genomic DNA extraction 
 
Cell pellets were digested overnight at 55°C in 1X TE buffer, with 0.1% SDS and 
200 µg/ml Proteinase K (Thermo Scientific). Nucleic acids were then extracted with 
phenol:chlorophorm:isoamyl alcohol (25:24:1) and subsequently with chlorophorm. 0.3M 
NaOAc (pH 5.5) in 1 time volume of 100% isopropanol or 3 times volume 100% EtOH was 
used to precipitate the genomic DNA. The DNA pellet was washed with 70% cold EtOH 
and finally resuspended in 1X TE buffer. Treatment of the DNA suspension with RNAse A 
for 30 minutes at 37°C assured digestion of left over RNA. Samples were stored at 4°C. 
 
 
2.2.2.2. Detection of 5meC - DNA immuno dot blot  
 
Genomic DNA was sonicated to 250bp and denatured for 10 minutes at 100°C. Cold 
2M ammonium acetate was used to stop the denaturing reaction. A sheet of filter paper 
and a nitrocellulose membrane were placed in a 96-wells dot blot apparatus (Bethesda 
Research Laboratories), the denatured DNA was loaded on the membrane in duplicate 
and then UV cross-linked. Membrane was blocked with 4% skimmed milk, 0.1% Tween20 
in 1X TBS buffer. Twin membranes were probed with primary antibody against either 
5meC or ssDNA (diluted 1:1000 in milk) and incubated shaking overnight at 4°C. The 
membranes were washed three times in 1X PBS with 0.1% Tween20, blocked and 
incubated with secondary antibody (donkey IR anti-mouse 800 or donkey anti-rabbit IR 
700, Li-COR Biosciences) at room temperature for minimum 1 hour. After a final wash with 
1X PBS the membranes were scanned with the LI-COR Odyssey Scanner.  
Intensity of the 5meC dots was calculated using the Image Studio software and 
normalised to the intensity of the ssDNA dots detected on the twin membrane.  
 61 
2.2.2.3. Detection of 5meC – High Pressure Liquid 
Chromatography (HPLC) 
 
After extraction and purification of gDNA, HPLC analyses were carried out by Dr. 
Ramsahoye as previously described (Ramsahoye, 2002). Triplicate measurement for each 
sample was performed and quantifications were calculated as area under each peak.  
 
 
2.2.2.4. Detection of 5meC - Bisulfite sequencing 
 
2 µg of DNA were converted using the EpiTect Bisulfite Kit (QIAGEN), following the 
manufacturer’s instructions. After conversion and amplification of the converted DNA, this 
was cleaned and the eluate was used for PCR for IAPs sequence, using the following 
conditions:  
    95°C for 5 min 
     95°C for 30sec 
     55°C for 30sec 
     72°C for 30sec à 2x22 cycles 
 72°C for 10min 
2 µl of PCR product were then used in a nested PCR reaction, using the following 
conditions: 
    95°C for 5min 
     95°C for 30sec 
     50°C for 30sec 
     72°C for 30sec à 2x26 cycles 
 72°C for 10min 
The whole PCR product was run on a 1% agarose gel and purified using the 
GeneJet Gel extraction kit (Thermo), following the manufacturer’s instructions. 12.5ng of 
purified PCR product were ligated O/N in a blunt vector, using the CloneJet PCR cloning 
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kit (Thermo), following manufacturer’s instructions. 100 µl of E.coli DH5α were 
transformed with half of the ligation reaction and incubated at 37°C O/N. To test the 
successful transformation of the bacteria, a colony PCR was performed, using the 
following conditions:  
    95°C for 5min 
     95°C for 30sec 
     60°C for 30sec 
     72°C for 45sec à 2x26 cycles 
 72°C for 10min. 
 
PCR products were then run on a 1%agarose gel to screen for positive clones. 
These were then cleaned of the PCR reaction solution using 10 µl of a clean-up solution. 
Samples were incubated for 20 min at 37°C and then for 15 min at 80°C. Finally, a 
sequencing reaction was performed, using the following conditions: 
    95°C for 1min 
     95°C for 30sec 
     50°C for 30sec 
     60°C for 4min à 2x25 cycles 
 16°C for 120min. 
Sequencing results were aligned using the DNA Lasergene software and the 




2.2.2.5. Detection of 5meC - Biotinilated CxxC Affinity 
Purification (BioCAP) sequencing 
 
BioCAP was performed as previously described by (Blackledge et al., 2012) and 
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optimised with the help of Dani Wicaksono (Buonomo’s lab) (Figure 5.1, page 106). In 
brief: E.coli BL21 were transformed with pHis-CxxC-Avi plasmid and 18kDa expressed 
protein was purified using Lysis Buffer and French® Pressure Cell Press. Protein was 
purified from the protein lysate using His-Bind Ni-NTA beads. His6-tag was removed by 
cleavage with His6-TEV protease O/N at 4 °C and the CxxC-Avi was biotinylated using 
Biotinylation Buffer (20 mM Tris pH 8.0 and 250 mM Potassium glutamate) and 5X Biomix 
(50 mM ATP, 50 mM MgOAc and 250 mM D-biotin). Once the CxxC-Bio was ready, the 
BioCAP reaction could be performed. 80 ng/μl of genomic DNA was sonicated in a 
Diagenode Bioruptor Twin to 100 – 300 bp long fragments. DNA was than quantified with 
Qubit BR dye on a Qubit fluorometer and dissolved in CAP100 buffer to a concentration of 
17.5ng/μl. 
25 μl Neutravidin beads (Sera-Mag Speedbeads – GE Life Science) were incubated 
with 25 μg of total Bio-CxxC. The beads-Bio-CxxC was then used for precipitation of 
sonicated gDNA at a maximum concentration of 17.5 ng/μl. After 1 hour of incubation at 4 
°C of gDNA and beads-Bio-CxxC, these were washed twice in CAP100 buffer and eluted 
in CAP300 buffer. This last step was repeated for elution in CAP500, CAP700 and 
CAP1000 buffers. The gDNA was purified from the beads by spin-column based 
DNA/PCR product purification kit (Invitrogen Purelink), following manufacturer instructions. 
Low salt (CAP300 and CAP500 eluate) and high salt (CAP700 and CAP1000 eluate) were 
pulled and only high salt fraction was used for sequencing analysis.  
Libraries for each sample to be sequenced were prepared using the NEBNext Ultra 
II DNA Library Prep Kit for Illumina, starting with 0.5ng of eluted DNA.  
Analysis of the sequencing results were performed in collaboration with Shaun 
Webb, as follow: 75b paired-end reads were aligned to the mouse mm10 genome with 
bwa mem version 0.7.5. We filtered the alignments to only include properly paired reads 
and to remove those that map to blacklisted regions identified by the ENCODE project. 
We further removed duplicate reads with Picard MarkDuplicates version 1.107. To account 
for varying read depths we used deepTools version 2.5.1 to create bigWig files normalised 
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by RPKM (reads per kilobase per million reads) for visualisation and further analysis. We 
employed Macs2 callpeak version 2.1.1 to characterise regions of non-methylated DNA 
within each sample and used the Bioconductor R package diffBind to identify regions of 
differential methylation between samples. 
Differential BioCAP-seq peak co-ordinates were intersected with regions of repeat 
families classified by the repeatMasker website. The significance of the number of 
overlaps was determined by permutation analysis using the peakPermTest function in 
ChIPPeakAnno with the total set of BIOCAP-seq peaks from all samples used as the 
background model. The background was randomly sampled 1000 times to select the 
same number of peak regions as the test set and to build a distribution of expected 
overlaps with repeat families. A p-value was calculated by comparing the mean of the 
expected distribution against the observed value and peak sets with a p-value <= 0.05 
were deemed to have a significant increase in overlap. 
 
 
2.2.2.6. RNA extraction, reverse transcription and 
quantitative RT-PCR  
 
When at 90 to 95% confluency, cells were harvested and collected in 2ml Eppendorf 
tubes. 1 ml of TRIzol Reagent (Thermo Fisher) was then used to resuspend the cell pellet. 
This was finally stored at -70°C. The RNA was extracted accordingly to manufacturer 
instruction. Briefly, aqueous phase was extracted with chloroform and nucleic acids were 
precipitated with 100% isopropanol. The RNA was then washed twice in cold 70% EtOH 
and air dried. The RNA pellet was then diluted in RNAse free water and treated with 
Ribolock RNAse inhibitor and DNAse I (Thermo Fisher) for 20min at 37°C, followed by 
heath inactivation for 5min at 95°C. To test for the quality of the RNA, 300ng of RNA were 
run on a 1.5% agarose gel, 10min at 90V.  
For the reverse transcription reaction, 2 µg of RNA were used, with 1µl of Oligo(dT) 
primers, 0.1M DDT, 10mM dNTPs, Ribolock RNAse inhibitors and 1µl of Superscript III 
 65 
reverse Transcriptase (Thermo Fisher). The produced cDNA was finally diluted in RNase 
free water and stored at -20°C. 
Analysis of the gene expression was performed by qRT-PCR in a Roche 480 
Lightcycler. SYBR Green master mix (Roche) and 2.5 µM primers were used according to 
manufacturer’s instructions. To ensure the efficiency and specificity of the primers, melting 
curves for each primer pair was analysed. Gene expression was then analysed using the 
double Delta Ct analysis, relative to the housekeeping gene Gapdh and then normalised 
to Day 0.  
 
2.2.2.7. Microccal Nuclease (MNAse) Assay  
 
20 million cells were harvested, trypsinised and washed in PBS 1X. Cells were then 
crosslinked for 10 minutes using 1/10 volume of 10X crosslinking buffer and 36.5% 
formaldehyde to 1% final concentration. The reaction was stopped by addition of 2.5M 
glycine and cell suspensions were centrifuged for collecting cell pellet.  
Cell pellet was homogenised in 500 μl of douncing buffer using a dounce 
homogeniser. 25 units of enzyme (300U/μl, Thermo Fisher) were used for each sample, 
which was incubated for 0, 3, 6, 9 and 12 minutes. The reaction was quenched using 
EDTA to 5mM final concentration. Samples were reverse crosslinked O/N at 65°C, with 
Proteinase K and 1%SDS.  
Digested and decrosslinked samples were purified using a spin-column based 
DNA/PCR product purification kit (Invitrogen Purelink) and eluted in 35 μl of TE buffer. The 







2.1.1. PROTEIN ANALYSIS 
 
 
2.1.1.1. Protein extraction 
 
Cells were harvested and cell pellet was resuspended in 1ml Hypotonic NE1 buffer 
and disrupted in a Dounce Homogeniser. Nuclei were precipitated by centrifugation at 4°C 
for 5 min at 4500rpm and resuspended in NE1 buffer with benzonase. NaCl was added to 
a final concentration between 200 and 500mM. Nuclear matrix and pellet were separated 
by centrifugation at 4°C for 15 min at 13000rpm.  
Protein concentration was measured using the Bicinchoninic acid assay (BCA) and 
protein extract was then stored at -70°C. 
 
2.1.1.2. Western blotting 
 
Nuclear extract was loaded on an 8% separating gel and then transferred on a 
nitrocellulose membrane for 1 hour at 400mA. Membranes were blocked with 4% milk, 
0.1% Tween20 in TBS buffer and probed over night with primary antibody against LSH 
(Santa Cruz), DNMT3B (Abcam), DNMT3A (Abcam), DNMT1 (Santa Cruz) and HDAC1 
(Santa Cruz). After three washes in PBST (0.1% Tween20), membranes were blocked 
and incubated with secondary antibody (donkey IR anti-mouse 800 or donkey anti-rabbit 
IR 700, Li-COR Biosciences) at room temperature for at least 1 hour. Membranes were 
finally washed with PBS and scanned at the LI-COR Odyssey Scanner. For histone 
analyses, PVDF membranes were preferred. Ethanol was used for activating PVDF 












Mammalian development is a complex and not fully understood process. The 
formation of the new individual is linked to changes occurring on a genome-wide scale and 
epigenome level. In fact, the epigenome is dramatically reprogrammed: immediately after 
the formation of the zygote, DNA methylation is erased, to then be re-established after 3.5 
days of development (He et al., 2011; Howlett & Reik, 1991; Li, 2002; Reik et al., 2001). 
Although a lot is known, it is still not completely clear how these changes occur and all the 
players involved in the process. Moreover, some loci escape reprogramming and do not 
lose and gain methylation at the same pace as the rest of the genome. These are imprinted 
regions and repetitive elements such as the type-II intracisternal A-particle (IAP) elements 
(Howlett & Reik, 1991; Smith et al., 2014). The difficulties in understanding this process are 
increased by technical limitations. In fact, obtaining enough material to study the first steps 
of development is challenging and time consuming. On the other hand, in vitro models are 
not very reliable for such studies and, although single cell analyses are now a possibility, 
this is not yet a routine approach in every lab.  
To overcome these limitations, new in vitro approaches have been developed. 
Embryonic stem cells (ESCs) derived from E3.5 blastocyst stage embryos have for long 
been used for in vitro studies to investigate the naïve state of pluripotency, characteristic of 
this point in development. ESCs are maintained in culture using foetal bovine serum and 
leukaemia inhibitory factor (LIF), which stops them from differentiating (Smith et al., 1988; 
Williams et al., 1988) by activating the JAK-STAT signalling pathway (Niwa et al., 1998). 
Although these cells are capable of self-renewal and differentiation, high levels of DNA 
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methylation characteristic of much later developmental stages highlighted that these cells 
do not properly represent the stage of development that they are derived from. Mainly, in 
2008 Ying et al showed that ESCs maintained in culture using serum are characterised by 
a very variable methylation profile. This is due to the oscillating pluripotency state of the 
cells: within the same cell culture, the cells show different levels of expression of 
pluripotency genes, such as Oct4, driven by variable response to the Fibroblast Growth 
Factor (FGF) signalling, which is contained in the serum used to maintain the mESCs. As a 
result, this culturing system imposes a high, on average, level of methylation in the cell 
population, when compared to the embryonic stage the cells derived from. The same group 
suggested the use of a different culture system enabling to maintain the naïve pluripotent 
state of the cells. This alternative system involves the use of supplements to substitute for 
nutrients in the serum and the addition of 3 small molecule inhibitors (3i), CHIR99021, 
PD184352 and SU5402, targeting respectively GSk3ß in the WNT cascade, MEK1/2 in the 
FGF cascade and finally the FGF receptor tyrosine kinase (Ying et al., 2008). Cells 
cultured in 3i medium were shown to be more homogeneous within the population, 
expressing stable levels of pluripotency factors and finally shown to have a much lower 
DNA methylation level. In the same year, it was proposed that the use of only two of these 
inhibitors, CHIR99021, PD184352, (2i) was sufficient to drive the ESCs to naïve 
pluripotency (Silva et al., 2009). Although mESCs maintained in both conditions, 3i and 2i, 
can be considered pluripotent, it is now commonly stated that the mESCs in 2i medium can 
be categorised as naïve pluripotent, whereas mESCs in serum medium are known as 
primed pluripotent ESCs. 
The mechanism leading to hypomethylation in presence of the 2 small molecules 
inhibitors is yet unclear. However, it is hypothesised that it could be determined by an 
interplay between passive and active demethylation and a reduced de novo DNA 
methylation activity, that overall lead to depletion of the mark. The altered signalling 
pathways have been shown to lead to the upregulation of transcriptional and epigenetic 
regulator PR Domain-Containing Protein 14 (PRDM14) (Okashita et al., 2014). On one 
hand, PRDM14 downregulates the de novo methyl transferases Dnmt3a and Dnmt3b 
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(Leitch et al., 2013), leading to impairment of the de novo DNA methylation. On the other 
hand, PRDM14 also targets TET1 and TET2 and enhances their recruitment to the 
designated loci, therefore inducing active DNA demethylation (Okashita et al., 2015). 
Finally, it was shown that GLP is repressed by PRDM14 (Leitch et al., 2013). This protein, 
in complex with G9a, is crucial to direct UHRF1 to the replication fork, via methylation of 
the DNA ligase 1 (Ferry et al., 2017), and consequently regulating maintenance of DNA 
methylation. Hence, when PRDM14 is upregulated in 2i, this could lead to an impairment of 
the maintenance of the DNA methylation, and therefore a passive demethylation (Leitch et 
al., 2016) (Figure 3.1).  
Importantly, it was shown that in the ESCs genome some regions are relatively 
resistant to hypomethylation, namely the Imprinting Control Regions (ICR) and the IAPs, 
while partial loss is reported for the major satellites (Ficz et al., 2013). 
We therefore decided to use the 2i culturing system to investigate LSH-dependent 
changes in DNA methylation that normally occur during the early stages of embryonic 
development. In particular, by keeping the cells first in serum medium and then switching 
them to 2i medium, the effects of lack of LSH on the demethylation and maintenance of 
methylation could be studied. Then, by changing the culturing conditions to serum-
containing medium, the role of LSH in de novo DNA methylation could be explored. 
Finally, taking the cells to the first stages of the differentiation by triggering the formation of 
Embryonic Bodies (EBs), allowed to better understand the involvement, if any, of LSH in 




3.2. Establishment of a cell culture system to mimic DNA methylation 
dynamics of early embryonic development  
 
First of all, the 2i culturing system had to be established in the Stancheva lab and 
tested. Heterozygous ESCs for Lsh, carrying the cassette on only one allele (Lshoff/+ 
ESCs), were used to optimise the culturing conditions. Cells were first maintained in 
serum-containing medium. Then, the cells were switched to the 2i-medium and kept for up 
to 16 days in this medium, determining the establishment of naïve state of pluripotency. 
After that, the naïve pluripotent mESCs where once again switched to serum-containing 
medium, determining the subsequent activation of the de novo methylation machinery, 
and maintained for a maximum of 16 days in this medium. This time was later decreased 
to 4 days, in order to more closely mimic the short time existing in vivo before the 
beginning of the differentiation stage of development. Finally, the primed mESCs were 
differentiated into EBs, by LIF withdrawal and addition of retinoic acid, to start the 
commitment to neuronal lineage (Figure 3.2). DNA methylation, RNA expression and 
protein expression analyses were performed every two days of culture, corresponding to 
the passaging of the cells.  
The cells reacted well to the medium containing the 2 inhibitors, showing no 
unexpected death or severe growth arrest. Immediately after switching to the 2i-medium, 
the cells were dividing slightly slower compared to the mESCs in serum-containing 
medium, but eventually the difference was minimised. As previously shown (Ying et al., 
2008), cells were forming tight colonies on the plate, rather than spreading as typically 
ESCs do when growing in serum supplemented medium (Figure 3.2 B and C). 
Furthermore, while some differentiated cells were visible in the serum-containing culture, 
all the cells in 2i-medium showed typical features of pluripotent cells, such as rounded 
shape, pigmented cytoplasm or growth in small colony-shaped aggregates. This was an 
indication of the naïve ground state of pluripotency of the cells in 2i-medium. When cells 
were switched back to serum-containing medium, the initial morphology was re-
established already after 2 days, showing that changes happening in the cells were easily 
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and quickly reversible (Figure 3.2 B). 
Since the culturing system worked well with these cells, we decided to proceed and 





3.3. Total DNA methylation of ESCs is lost in 2i and re-established in 
serum culturing condition  
 
Since the cells were showing to be responsive to the different culturing conditions, 
global DNA methylation levels were analysed initially by using an antibody against 5-
methyl cytosine (5meC) on denatured DNA dot blots. Quantification of the amount of 
5meC was performed over the amount of ssDNA present on the blot. 
 It was previously reported that the DNA methylation of ESCs maintained in 2i-
medium decreases rapidly and reaches a steady state at around 30% of the initial value 
(Ficz et al., 2011). As shown in Figure 3.3, DNA methylation in Lshoff/+ ESCs dropped by 
more than half of the initial methylation level at 4-day time point in culture supplemented 
with the 2 inhibitors. After 8 days in 2i-medium, global DNA methylation finally reached 
30% of the initial 5meC level, as expected, and stayed mostly stable. Interestingly, the dot-
blot analysis showed that the restoration of DNA methylation did not require similar time to 
that required for demethylation. In fact, the methylation was restored in 4 days of culture in 
serum-medium after the time in 2i (Figure 3.3 A and B).  
These results showed that global levels of 5meC decrease in Lshoff/+ ESCs when 
cultured in 2i-medium and that this hypomethylation is quickly recovered. Furthermore, a 
time window was established, to optimally study the dynamics of these changes. More 
specifically, at least 12 days of culture in 2i-medium are necessary to deplete the global 
DNA methylation by 70% and, on the other hand, 4 days in serum-containing medium are 
enough to restore the global methylation. However, the dot-blot approach has big 
technical limitations, such as the quantification limit of the antibody-based detection and 
reproducibility of the technique. In addition, RNA contaminations are not detectable and in 
fact affect the quantification of the 5meC. Therefore, the quantification of global DNA 





Figure 3.3 Total DNA methylation of ESCs is lost in 2i and re-established in serum-containing 
culture conditions
A. In the left panel, global DNA methlation was detected by an anti 5meC antibody on a DNA dot blot. 
In the right panel, DNA loading was quantificatied by an anti ssDNA antibody on an identical dot blot. 
Serial dilutons of DNA were used, with the highest concentration beeing 1µg. 
B. Quantification of the 5meC, relative to the loaded ssDNA. The values are shown relative to Day 0 and
expressed as a percentage. The methylation drops in 2i-medium and is restored quickly in serum-
containing culture conditions.
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Altogether, these experiments indicated that this system could be efficiently used 
with Lshoff/+ mESCs to study DNA methylation changes. Testing the expression of DNMTs 
was then necessary to understand if the regulation of the system could be analysed within 
this time-frame in culture.   
 
 
3.4. Protein and RNA levels of DNMTs and PRDM14 are differentially 
regulated in 2i- and serum-containing cultures  
 
The hypomethylation typical of ESCs cultured in 2i-medium is accompanied and 
supported by regulation of the DNA methyltransferase enzymes. More specifically, 
Western blot analysis has previously shown that when the cells were cultured in this 
medium increased expression of PRDM14 was observed, which then led to 
downregulation of the de novo methyltransferases DNMT3A and DNMT3B (Ficz et al., 
2011). However, DNMT1 was not affected and appeared stably expressed. This regulation 
can be detected at the mRNA level as well, indicating that the mechanism regulating the 
depletion of 5meC occurs on a gene expression more than on protein level.  
Protein abundance analysis by Western blotting of extracts obtained from Lshoff/+ 
ESCs maintained first in serum-containing medium and then in 2i-medium showed that 
DNMT3B and DNMT3A are down regulated when the cells are cultured with the inhibitors 
for 12 days. The methyl transferases were then upregulated again when the cells were 
cultured in serum-containing medium, showing that the downregulation is only transient 
and can be quickly reversed. In contrast to what was previously reported (Leitch et al., 
2013), Western blot analysis showed that both DNMT3A isoforms were downregulated in 
2i-medium  (Figure 3.4 A).  
Importantly for our study, the expression of LSH protein in 2i-medium maintained 
cells had never been analysed before. Therefore, we decided to investigate the LSH 
protein levels by Western blotting and found that LSH was not downregulated in this 
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system (Figure 3.4A). This indicates that the signalling pathway that leads to the 
hypomethylation does not involve LSH regulation on either RNA or protein level and will 
therefore be possible to discern the effect of lack of LSH from the effects induced by the 
2i-medium. Interestingly, it appeared that LSH was upregulated once the cells were 
moved back to the serum-containing medium. It was previously hypothesized that LSH is 
expressed especially in highly proliferating cells (Lee et al., 2000; Raabe et al., 2001). This 
might suggest that the transiently increased expression of LSH in serum, after culturing in 
2i-medium, could be linked to the proliferative state of the mESCs.   
Analysis of the mRNA levels in the same system confirmed what was detected at 
protein level. In fact, Dnmt3a and Dnmt3b were downregulated in naïve pluripotent cells, 
and upregulated in primed cells. On the other hand, Prdm14 was upregulated in 2i 
medium-maintained cells and then downregulated in serum, as expected. Finally, to verify 
the hypothesis that upregulation of Prdm14 might lead to an effect on the amount of G9a 
protein, via its target activity on GLP (Leitch et al., 2013), qRT-PCR was performed. G9a 
expression does not change between culturing conditions, suggesting that its expression 
is not affected by the 2 inhibitors (Figure 3.4B).  
These experiments show that the regulation of methyltransferases occurs as 
expected in 2i-medium and either 12 or 16 days in 2i are sufficient to establish these 
changes. Furthermore, the mRNA and protein expression profiles changed rapidly in 
serum and were discernible after 8 days of culture in serum-containing medium on a 
protein level. Therefore, it was decided to culture the cells for a shorter time with serum 
after 2i, in order to mimic more closely the short time that occurs in vivo between the 
beginning of the de novo methylation wave and the differentiation (He et al., 2011; Howlett 
& Reik, 1991; Li, 2002; Reik et al., 2001). 
Importantly, the 2i culture conditions apparently had no effect on either the 
expression or stability of LSH. Therefore, the system can be used reliably to study the 
consequences of the absence of LSH, concomitantly with changes in DNA methylation. 
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Figure 3.4 Protein and RNA levels of DNMTs and PRDM14 are differentially regulated in 2i-medium.
A. On the left, Western blots of nuclear extracts from cells grown with serum, 2i and returned to serum-
containing medium are shown. The blots were probed with antibodies against LSH, DNMT3B, DNMT3A 
and HDAC. While DNMT3B and DNMT3A are downregulated in 2i-medium, LSH is expressed at all points 
of the experiment. HDAC was used as a loading control. On the right, quantification of protein expression 
shown as average of 3 technical replicas, normalised to HDAC and relative to D0.
B. RNA expression analysis by quantitative PCR of DNMT3B, DNMT3A, G9a and PRDM14 in cells grown in
serum, 2i and serum again. GAPDH was used as an internal control. Quantification of the RNA 
expression is shown as average of 3 technical replicas, normalised to GAPDH and relative to D0.



















































































Understanding the role of LSH in early mammalian development is crucial to shed 
some light on its importance in the healthy adult, as well as individuals affected by 
disease, such as ICF. We decided to overcome the difficulties in the study of initial phases 
of mammalian development by taking advantage of different culture conditions established 
for ESCs, namely serum-containing or 2i-containing cultures. However, before exploring 
the effects of the absence of LSH in these cells, it was important to assess that the system 
performed as expected. To do so, heterozygous Lshoff/+ ESCs were used to set up the 
system.  
These preliminary experiments showed that culturing Lshoff/+ ESCs in 2i-medium 
does not lead to either growth arrest or cell death. Also, the cells showed very similar 
features to what was previously reported in literature. In particular, DNA methylation level 
decreased after 8 days in 2i-containing medium, showing that the inhibition of WNT and 
FGF signal cascades is efficient in these cells. The methylation loss was accompanied by 
downregulation of the de novo methyltransferases, and upregulation of Prdm14, as 
expected. Furthermore, switching the cells back to serum-containing medium efficiently 
restored the global DNA methylation levels. The restoration of the DNA methylation was 
associated with upregulation of the de novo methyl-transferases and downregulation of 
transcriptional regulator, Prdm14. 
Interestingly, LSH protein expression level did not change when the cells were 
cultured with the addition of the inhibitors for 4 days. This indicates that, even though LSH 
is hypothesized to be involved in the de novo DNA methylation, its protein and mRNA 
levels are not regulated by the same signalling pathways as those of the de novo DNA 
methyltransferases and therefore not affected by CHIR99021 and PD184352 in the 
culture.  
Finally, adjustments of the time in culture proved to be necessary in order to achieve 
the optimal time-frame allowing demethylation and remethylation to take place, while 
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analysing in parallel the effects of LSH absence.  
From these preliminary data, the system overall proved efficient and suitable to 





































Epigenetic regulation is essential for the correct function of the cell. This regulation 
can occur via different mechanisms, namely either via RNA-based regulations or histone 
modifications and DNA methylation. It has been previously shown that the protein LSH is 
central for regulation of DNA methylation in mammals and plants. Its plant homologue, 
Decrease in DNA methylation-1 (DDM1), was firstly found to be essential for DNA 
methylation in Arabidopsis thaliana. In fact, absence of the protein leads to loss of 70% of 
the DNA methylation in ddm1 mutant plants (Kakutani et al., 1995; Vongs et al., 1993). 
Later studies in mice have shown a role of LSH in methylation in mammals as well 
(Geiman et al., 2001). In fact, LSH-null mice die shortly after birth and display kidney 
failure and reduced birth weight, which are accompanied by hypomethylation of the 
genome. It is therefore clear that one of LSH main functions is regulating DNA methylation 
and this is conserved between species. Since these publications, a lot of work has been 
done to elucidate the role of LSH in DNA methylation.  
Recently, the Stancheva lab produced mice from Lshoff/+ ESCs (data not published). 
These mice, contrary to the previous models, can develop and live after birth, despite 
showing reduced weight and a shacking phenotype from early age. Importantly, this 
mouse model, like its predecessors, is also characterised by reduced DNA methylation. 
More specifically, experiments at day 12.5 of the embryonic development (E12.5) in the 
Lshoff/off and Lshoff/+ mice, showed that absence of LSH results in 40% decrease of DNA 
methylation in the Lshoff/off embryos and mice, while the Lshoff/+ are not affected. 
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Although a role of LSH in DNA methylation is clear, it is only hypothesized, but not 
directly proven, that it plays a role early in development, most probably before E12.5. 
During these first phases of the mammalian development, both the de novo DNA 
methylation and maintenance of the newly deposited methyl groups are important. It still 
remains unclear whether LSH is involved in one or both these processes, as shown by the 
numerous contradicting studies trying to address this question. 
After establishing a system that could allow to recapitulate in vitro the 
reprogramming of the epigenome in vivo, DNA methylation and hydroxyl-methylation were 
analysed in absence of LSH. These experiments would help shedding some light on the 
role of LSH in the early phases of mammalian development.  
 
 
4.2. The absence of LSH affects the loss and gain of DNA methylation  
 
In order to investigate the DNA methylation dynamics in Lshoff/off ESCs compared to 
Lshoff/+ ESCs, both cell lines were cultured in the culturing system described in the 
previous chapter. After a short period in serum-containing medium, the cells were grown in 
2i-supplemented medium. Finally, 16 days of culturing in this medium were chosen as the 
most representative time point for the experiment. Subsequently, an optimization step was 
carried out to determine for how long the cells needed to be grown in serum-containing 
medium. Aiming to have a representation of the short period of time that elapses between 
the initial de novo methylation and the starting of the differentiation, 4 days of culturing in 
serum-containing medium after 2i were chosen. After 4 days, the cells were taken through 
the initial stages of differentiation by withdrawal of LIF in non-adherent culture conditions 
for 4 days. Addition of retinoic acid then induced the cells to committing to neuronal cells 
lineage and a final time point at 8 days of culture was established to detect the changes in 
DNA methylation occurring following the initial phases of differentiation (Mohn et al., 
2008). Analysis of the population doubling of Lshoff/off ESCs compared to Lshoff/+ ESCs 
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showed no significant difference between cell lines, when grown in the same conditions 
(Figure 4.1A). To ensure that Lshoff/off ESCs were not expressing LSH and that this 
depletion was constant in the different culturing systems, western blot analysis was 
performed. As expected, no protein expression was detected in cells maintained in serum 




 Genomic DNA was extracted at each time point and analysed by High-performance 
Liquid Chromatography (HPLC), as previously described (Ramsahoye, 2002). This is a 
very accurate technique to quantify the total amount of 5meC present in the sample, as 
well as the total h5meC.  
Figure 4.1.Lshoff/off ESCs grow similarly to Lshoff/off ESCs and do not express LSH protein.
A.Population doublings of Lsh off/+ ESCs in serum and 2i compared to Lsh off/off  ESCs in serum and 
2i-containing medium. The two cell lines behave almost identically in both co-colturing conditions.
B.Western blots of nuclear extracts from ESCs grown with serum or 2i-containing medium are shown. 
The blots were probed with antibodies against LSH and HDAC. While LSH is expressed in Lsh off/+ ESCs
at all stages of the time course experiment, as expected Lshoff/off ESCs do not show any expression of 















































At the start of the experiment (day 0), the Lshoff/off ESCs displayed lower DNA 
methylation level compared to the Lshoff/+ ESCs (Figure 4.2A). Surprisingly, however, the 
difference in methylation detected between the cell lines was smaller than what was 
previously shown for mouse embryonic fibroblasts (MEFs) and E12.5 embryos. However, 
this could be explained with the characteristics of the samples. In fact, these cells were 
genetically modified in vitro for the introduction of two copies of the cassette, kept in 
culture and frozen. This means that any difference in the methylation could have only 
occurred in vitro, whereas the previous data was obtained from cells that had gone 
through the formation of a mice embryo.   
Once the cells were moved to the 2i-containing medium and the demethylation 
process started, both cell lines lost DNA methylation, but not equally. More specifically, the 
Lshoff/+ ESCs lost half of their methylation after only 4 days in 2i and then reached a steady 
state of approximately 1.2% of total 5meC, which is approximately 30% of the initial value. 
This is consistent with what we previously detected by dot-blot analysis (Figure 3.3). On 
the other hand, the Lshoff/off ESCs in 4 days lost half of their initial DNA methylation to then 
continue losing 5meC in the following days, dropping it to 0.5%, which is approximately 
13% of the initial DNA methylation level. These results indicate that the global loss of DNA 
methylation is exacerbated in the absence of LSH. However, at this stage the mechanism 
by which the loss is increased is not clear. In fact, this significant difference might occur as 
a result of either a more open chromatin state in cells lacking LSH, which therefore might 
render the genome more accessible to demethylases, or be caused by increased activity 
of the demethylases, such as the TET enzymes, or finally stem from impaired 
maintenance of DNA methylation at replication foci, which would point to a role of LSH in 
maintenance of DNA methylation.  
When the cells were switched to serum-containing medium, the DNA methylation 
was expected to be restored, as a consequence of the expression of the de novo methyl-
transferases, DNMT3A and DNMT3B. Indeed, DNA methylation levels were restored in 
both cells types, but after 4 days in serum-containing medium, they were still significantly 
lower in Lshoff/off ESCs (Figure 4.2A). This might indicate a slower rate of recovery or an 
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impairment of the de novo methylation in cells lacking LSH. 
Early phases of differentiation are characterised by silencing of pluripotency genes 
and activation of lineage specific ones. Also, cells grown as embryoid bodies stop dividing 
at day 4 due to addition of retinoic acid and dramatically decrease expression of the de 
novo methyl-transferases. In our culture system, at day 4 of the EBs differentiation the 
5meC, interestingly, reaches higher levels if comparing to the DNA methylation detected 
at the beginning of the experiment. Then, after addition of the RA, the EBs start 
expressing lineage specific genes and this seemed to be accompanied by a decrease in 
the levels of DNA methylation after 8 days of culture (Figure 4.2A). The changes at this 
stage were similar in both the Lshoff/off and Lshoff/+ EBs. However, the decrease in 5meC at 
this stage was significantly more substantial in the Lshoff/off EBs. Despite the observation 
that de novo DNA methylation occurred efficiently even in the absence of LSH, the 
difference detected in EBs at day 8 suggests an impairment of this process. Furthermore, 
the inability of the Lshoff/off ESCs to completely compensate for the difference in global 
DNA methylation established after the demethylation phase in 2i might indicate that a 
proportion of the genome cannot be methylated efficiently in the absence of LSH. 
Altogether, these data suggest that activity of LSH is required to correctly complete the de 
novo methylation.    
The representation of the data as a histogram gave a good understanding of the 
5meC level at each time point and of any difference existing between the Lshoff/off and 
Lshoff/+ ESCs. However, it was difficult to compare the overall dynamics of the changes 
and to highlight any difference in removal and accumulation of 5mC on the DNA over time. 
This is especially true due to the difference in the de novo methylation, as the recovery 
starts from very different levels in the Lshoff/off and Lshoff/+ ESCs. Therefore, we decided to 
display these data by dividing them into two plots, one representing the demethylation and 
one the de novo methylation rate normalizing to the starting point of each process, for 
each cell line. As a result, in each plot, the value of the first time point (day 0 or day 16 2i, 
respectively) was plotted as 1 for Lshoff/off and Lshoff/+ ESCs and the following values 
presented relative to 1 (Figure 4.2B and C).      
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The rate of demethylation was similar for the two genotypes (Figure 4.2B). 
Normalisation to 1 clearly showed that the 5meC decreases by half after 4 days and by 
25% more after 8 days in both of Lshoff/off and Lshoff/+ ESCs. As obvious from the 
histograms, while Lshoff/+ ESCs reach a steady state in the DNA methylation levels, 
Lshoff/off ESCs continue losing 5meC. The reasons behind this further loss is however not 
clear, as discussed above.  
Surprisingly, when the rate of DNA methylation gain upon recovery from 2i was 
displayed relative to day 16 in 2i, the accumulation of 5meC was very different between 
the two cell lines (Figure 4.2C). In fact, the Lshoff/+ ESCs displayed a 4-fold increase of 
5meC at 4 days as EBs, after which 5meC decreases, as expected due to the initiation of 
the differentiation process. Despite the similar trend in Lshoff/off ESCs, there was a 8-fold 
increase in the methylation at day 4 of the differentiation process. Since the absolute 
amount of methylation on the DNA was smaller, this suggests that in the same time 
period, more methyl groups accumulate on DNA in LSH-deficient cells. However, this is 
still not sufficient to completely compensate for methylation differences between the 
Lshoff/off and Lshoff/+ ESCs. This faster accumulation of 5mC can be explained by a more 
open chromatin state, which allows easier access to the de novo methyl transferase 
enzymes. It could potentially also be a consequence of an increased synthesis of methyl 
transferases, which would then operate faster on multiple loci in the genome.  
Altogether these results show that the absence of LSH influences DNA methylation, 
as previously shown for later developmental stages. However, the system used here 
enable us to hypothesise that LSH is important earlier in development than previously 
reported. Furthermore, it seems clear that the lack of LSH affects both the dynamics of 
demethylation and the de novo methylation. However, it is still not evident how.  
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Figure 4.2.The absence of LSH affects the loss and gain of DNA methylation. 
A. HPLC analysis of 5meC, as a percentage of the total C in the genome. Days and culturing conditions
are annotated on the x axis (D0= cells in serum, D4/8/12/16 2i=4/8/12/16 days in culture with 2i medium, 
D2/4 Ser= 2/4 days in culture in serum-containing medium, D4/8 EBs=4/8 days into the formations of 
embryoid bodies). n=6 biological replicas; * indicates p-value < 0.05
B. Dynamic of DNA demethylation  in Lsh off/+ and Lsh off/off  ESCs. The fold change in 5meC is shown 
relative to D0.  
C. Dynamic of de novo DNA methylation in Lsh off/+ and Lsh off/off  ESCs. The fold change in 5meC is shown 
relative to D16 in 2i.
Error bars represent the standart deviation between biological replicas; p-values determined by 
Student’s t-test. The percentage of methylated cytosine was calculated as percentage of the total cytosine 
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4.3. The loss of 5meC in Lshoff/off ES cells correlates with 
accumulation of 5hmeC  
 
The previous experiments showed that the absence of LSH leads to a bigger loss of 
5meC in naïve pluripotent ESCs. A mathematical model was used to explain that the main 
mechanism involved in loss of DNA methylation in this culturing system is the impairment 
of maintenance (von Meyenn et al., 2016). However, in this system we observed a 
different response in cells lacking LSH to what expected. The deeper loss described could 
be explained by either an increase in active DNA demethylation or an impairment of 
methylation maintenance when the cells are cultured in 2i-containing medium.  
The 5hmeC is formed by oxidation of the 5meC by the TET oxygenase enzymes 
(Figure 1.4). This is the first step of the demethylation process, which requires 2 more 
oxidative steps to be completed. The TET enzymes further convert the 5hmeC to 5-
formylcytosin (5fC), and finally to 5-carboxylcytosine (5caC). The final step of removal of 
the modification from the bases is thought to involve the Thymine DNA Glycosylase (TDG) 
enzyme, which is part of the Base Excision Repair (BER) machinery (Kohli & Zhang, 
2013). Therefore, the active removal of 5meC is typically accompanied by accumulation of 
5hmeC. Importantly, it has been shown that PRDM14 upregulation leads to increased 
expression of the Tet enzymes in cells cultured in 2i-containing medium. Consequently, in 
these cells the 5hmeC levels are higher (Okashita et al., 2014).  
On the other hand, when the maintenance of the DNA methylation is impaired, the 
DNA is not methylated on the newly synthesized strand at the replication fork. Thus, the 
5meC is passively lost by dilution of the modification concomitantly with the cell division. 
When this happens, an increase of the amount of total 5hmeC is not detectable.    
Therefore, in order to elucidate which mechanism is the main responsible for the 
increased demethylation in absence of LSH, the hydroxyl-methyl-cytosine (5hmeC) was 
measured by HPLC. Genomic DNA was extracted and analysed for both 5meC (Figure 
4.3) and 5hmeC by HPLC. When 5hmeC was analysed as percentage of the total cytosine 
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(Figure 4.3A) at day 0, the amount of this modification in the two cell lines was very 
similar. Then, a 2.5 fold increase in 5hmeC was detected in the cells cultured in 2i-
containing medium, particularly in the first passages in this medium, corresponding to the 
main demethylation events (Figure 4.3A). Although there is slightly more 5hmeC in the 
Lshoff/off ESCs at day 4 in 2i-containing medium compared to the Lshoff/+ ESCs, this 
difference is not significant and later in the time course experiment it becomes negligible. 
Notably, there is a big variation between measurements of the 5hmeC. This is an issue 
when performing statistical analysis, as no significant difference can be established. 
However, this variation is due to technical limitations, as the amount of hydroxylated 
cytosine in the genome is very small and this affects the accuracy of quantification. 
Expressing the amount of 5hmeC as percentage of 5meC (Figure 4.3 B) enabled us 
to determine how much of the measured methylated cytosine was actually being removed 
from the DNA. In this case as well, there was no significant difference between the two cell 
lines in the amount of 5hmeC at day 0. This was followed by a 3 to 4 fold increase in 
hydroxymethylation in 2i-medium. In fact, in both cell lines the 5hmeC levels in 2i stayed 
higher than at day 0 and until the cells were switched back to serum-containing medium. 
Moreover, 5hmeC decreased of about 40% in Lshoff/+ ESCs after 4 days in 2i-containing 
medium, indicating that at this stage all the accessible methyl groups had been removed 
from the cytosine. Interestingly, this was not the case for Lshoff/off ESCs. More specifically, 
in the absence of LSH a higher portion of 5meC was oxidised when the cells were cultured 
in 2i-containing medium and these levels were maintained constantly around 10% of the 
5meC until the cells were switched back to serum-containing medium. This suggests that 
some methyl groups were still accessible to the TET activities in the genome of Lshoff/off 
ESCs and could be removed, consistently with the more pronounced decrease of 5meC 
shown in the previous experiment (Figure 4.2).  
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Figure 4.3. The loss of 5meC in Lsh off/off  ES cells correlates with accumulation of 5hmeC. 
A. HPLC analysis of 5hmeC, as a percentage of the total C in the genome. Days and culturing 
conditions are annotated on the x axis (D0= cells in serum, D4/8/12/16 2i=4/8/12/16 days in culture 
with 2i medium, D2/4 Ser= 2/4 days in culture in serum-medium, D4/8 EBs=4/8 days into the formations 
of Embryoid bodies). n=5 biological replicas; * indicates p-value < 0.05. The percentage of methylated 
cytosine was calculated as percentage of the total cytosine present in the genome analysed. 
B. HPLC analysis of 5hmeC, as a percentage of 5meC in the genome. Days and culturing 
conditions are annotated on the x axis.n=5 biological replicas; * indicates p-value < 0.05
Error bars represent the standart deviation between biological replicas; p-values determined by 























































































These findings suggest that most of the loci are rapidly demethylated both in Lshoff/off 
and Lshoff/+ ESCs, when the cells are shifted to 2i-containing medium. However, in the 
absence of LSH the active demethylation can continue and occurs at more loci in the 
genome, causing a further accumulation of 5hmeC, until the cells are moved back to 
serum-containing medium. Therefore, some loci might be accessible to the TET enzymes 
only in cells lacking LSH, however, it is yet unclear which loci and why. It was previously 
shown in vitro that TET enzymes have a preference for open chromatin rather than for 
compacted chromatin. Consequently, it could be hypothesised that, when LSH is depleted, 
a more open chromatin environment is established and this might lead to a wider access 
to the genome of the TET enzymes, which can then oxidise more cytosine.  
Altogether, these data seem to support the hypothesis that the lower level of 5meC 
occurring in naïve pluripotent ESCs lacking LSH is determined by an active demethylation, 
ruling out a possible role of LSH in the replicative maintenance of DNA methylation.   
 
 
4.4. Removal of facultative heterochromatin has an additive effect 
on the loss and gain of 5meC and 5hmeC in Lshoff/off ES cells  
 
Heterochromatic regions of the DNA are characterised by the presence of DNA 
methylation as well as specific histone marks. These are chemical modifications of the 
histone tails and can have a role in activation or repression of gene expression. The most 
important modifications for gene silencing are di- and tri-methylation of histone H3 at 
lysine 9 (H3K9me2/3) and tri-methylation of H3 at lysine 27 (H3K27me3). H3K9me2 is 
deposited mostly by the G9a/GLP methyl transferases complex, which is highly abundant 
in ESCs. H3K9me2 is also abundant in both pluripotent stem cells and differentiated cells 
(Lienert et al., 2011) covering about 50% of the genome in ESCs maintained in serum- 
containing medium and 53% of the genome in neuronal cells derived from ESCs. 
Interestingly, the domains of H3K9me2 are stable and, despite what was previously 
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thought, the difference between ESCs and differentiated cells is minimal and includes 
mostly newly established H3K9me2 domains at gene bodies in differentiated cells. 
However, it was subsequently shown that when ESCs are cultured in 2i-containing 
medium, H3K9me2 is depleted from most of the genome. Interestingly, this loss does not 
affect H3K9me3, which remains stable when the cells are driven to a naïve state of 
pluripotency (Walter et al., 2016). This suggests a specific role of the H3K9me2 in early 
stages of differentiation and the establishment of so called facultative heterochromatin. 
Furthermore, this modification is typically associated with lamina-associated domains 
(LAD) (Towbin et al., 2012; Wen et al., 2009) and has been shown to cooperate with 
H3K27me3 to relocate chromatin to the nuclear periphery (Harr et al., 2015). 
LSH was shown to support DNA methylation at LADs (Yu et al., 2014), some of 
these chromatic regions are in fact demethylated in Lsh-/- MEFs. Furthermore, absence of 
LSH was shown to compromise recruitment of the G9a/GLP complex at a subset of loci, 
determining hypomethylation of the locus (Myant et al., 2011). However, no direct 
interaction between LSH and the histone methyl transferase complex was detected. 
Therefore, we hypothesise that LSH supports DNA methylation by remodelling 
heterochromatin at H3K9me2-marked LADs and thereby facilitating DNA methylation at 
these loci, concomitantly with de novo methylation. Thus, depletion of H3K9me2, and 
therefore heterochromatin, by inactivation of G9a, could promote accessibility of the 
chromatin for deposition of the methylation on the DNA, bypassing LSH activity. 
 To test this hypothesis, Lshoff/off and Lshoff/+ ESCs were treated with an inhibitor of 
the G9a/GLP methyltransferase complex, UNC0638. This small molecule inhibits the 
catalytic activity of the complex by acting as a strong competitor of H3K9me2 and 
occupying the substrate binding groove of G9a (Vedadi et al., 2011). The cells were 
treated with UNC0638 for 4 and 8 days and then tested by Western blotting for the 
depletion of H3K9me2. As expected, 4 days of treatment were sufficient to deplete most of 
H3K9me2 from chromatin of the inhibitor-treated cells (Figure 4.4B), with the cells still 
being able to divide. For the time course experiment to analyse the 5meC, the cells were 
treated for 6 days with UNC0638 prior to the switch to 2i-contaning medium (Figure 4.4A) 
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to allow sufficient time for dilution of H3K9me2 before starting the time course experiment. 
Cells of the same genotypes without treatment were used as a control. DNA methylation 
and hydroxymethylation were then analysed by HPLC.  
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Treating the cells with UNC0638 led to a decrease in the total cytosine methylation 
in serum, probably indicating impairment of the G9a-dependent DNA methylation 
maintenance (Shinkai & Tachibana, 2011; Tsumura et al., 2006) both in Lshoff/off and 
Lshoff/+ ESCs (Figure 4.5 A). Subsequently, the change of culturing conditions led to a 
quick decrease of DNA methylation from 3 to 1% in only 4 days in Lshoff/+ ESCs. In Lshoff/off 
ESCs, this decrease was even faster, reaching 0.5% at 4 days in 2i-medium. In both cell 
lines, the loss of methylation was more substantial than in the untreated with the inhibitor 
control cell lines. While cells lacking LSH kept loosing DNA methylation further, reaching 
0.3% in 16 days, Lshoff/+ ESCs reached a steady state and maintained around 1% of the 
cytosine methylated, consistently with what occurred in the absence of UNC0638 
treatment.  
After activation of the de novo methylation machinery in serum, both cell lines were 
able to methylate the DNA in 4 days. However, only Lshoff/+ ESCs showed a complete 
restoration of DNA methylation to initial values thus overcoming completely the 
maintenance defect caused by inhibition of G9a/GLP. On the other hand, Lshoff/off ESCs 
restored only 66% of the initial DNA methylation, recapitulating again the what occurred in 
the untreated control (Figure 4.5A). 
Finally, when cells proceeded through the initial phases of differentiation and formed 
EBs, in both cell lines DNA methylation initially increased. Interestingly, at day 8 of 
differentiation some of the DNA methylation was lost, especially in Lshoff/off EBs. In fact, 
the 5meC decreased from the 3.8% to 2.8% in UNC0638 treated cells. The same trend 
was detected in the untreated control. At this stage, the difference in methylation detected 
between Lshoff/off and Lshoff/+ EBs is more substantial than the difference detected at the 
ESCs stage (Figure 4.5A).  
In order to have a better understanding of the dynamics of these changes, the data 
were plotted as two separate graphs, demethylation and de novo methylation, as 
explained above (chapter 4.2). The 5meC was lost more quickly in the presence of 
G9a/GLP inhibitor in both Lshoff/off and Lshoff/+ ESCs (Figure 4.5 B). More specifically, after 
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4 days of culturing in 2i-medium, while the untreated control lost 50% of the initial DNA 
methylation, Lshoff/+ ESCs treated with the inhibitor lost 68% of the initial 5meC and 
Lshoff/off ESCs treated with the inhibitor dropped to 0.12, corresponding to a loss of 88%. 
Hence, this effect could be attributed to the depletion of H3K9me2 histone modification. 
Interestingly, while Lshoff/+ ESC grown with UNC0638 had similar levels of DNA 
methylation as those of the untreated control by day 16 in 2i, Lshoff/off ESCs treated with 
UNC0638 lost even more 5meC than their untreated counterparts, reaching 92.3% 
decrease compared to 88% of the control cell line (Figure 4.5 B). This suggests that the 
depletion of facultative heterochromatin and the absence of LSH have additive, yet 
independent, effect.  
When exploring the de novo DNA methylation dynamics, surprisingly, the 
accumulation of methyl groups had similar trend in all the cell lines, but very different rates 
(Figure 4.5C). As seen above from these data analyses (Figure 4.2C), Lshoff/off ESCs in 4 
days in serum medium accumulate more methyl groups than the Lshoff/+ ESCs, while 
maintaining lower absolute levels of DNA methylation in the genome. The treatment of the 
cells with the UNC0638 accentuates this difference, by increasing the deposition (Figure 
4.5C). A 4-fold difference in deposition rate was detected between in Lshoff/off and Lshoff/+ 
ESC grown with UNC0638, while the control cell lines differed by 2-fold. Importantly, this 
difference was dependent on an increased accumulation rate in Lshoff/off ESCs depleted of 
H3K9me2 compared to the untreated counterpart, as Lshoff/+ ESC only increase by 1 fold 
in the rate of change compared to the cells not treated with the inhibitor (Figure 4.5C).  
Altogether, these data suggest that the effect of the depletion of H3K9me2, and 
therefore increase in accessibility of the chromatin, has a similar effect on DNA 
methylation deposition as the absence of LSH. This supports the hypothesis that the 
absence of LSH leads to a more open state of chromatin which facilitates the action of 
DNA demethylase enzymes. Furthermore, this experiment highlights an interplay between 
LSH and G9a in the deposition of methylation in early differentiation. More specifically, in 
these experiments the inhibition of G9a resulted in an amplification of DNA methylation 
effects detected in the previous experiments. Therefore, if LSH is responsible for 
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facilitating DNA methylation of heterochromatic regions of the genome, and the permanent 
silencing of these loci, G9a might be essential for methylating the histone tails of the same 
loci. Alternatively, G9a might be required to a different subset of genomic loci to those that 
require LSH and the effect that we detected could be linked to the depletion of 5meC at 
the two separate subsets. However, Lshoff/+ ESC treated with the UNC0638 showed very 
similar behaviour in terms of DNA methylation dynamics to the untreated cells. Therefore, 
the increase in the DNA methylation deposition rate is more plausible to be attributed to a 
combined effect, rather than to independent changes occurring are G9a-dependent 
regions.    
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Figure 4.5. Removal of facultative heterochromatin has an additive effect on loss and gain 
of 5meC and 5hmeC in Lshoff/off ES cells. 
A.HPLC analysis of 5meC, as a percentage of the total C in the genome. Days and culturing conditions
are annotated on the x axis (D0= cells in serum, D4/8/12/16 2i=4/8/12/16 days in culture with 2i medium, 
D2/4 Ser= 2/4 days in culture in serum-medium, D4/8 EBs=4/8 days into the formations of Embryoid 
bodies).Treatment with the G9a/GLP inhibitor is indicated as +UNC. n=3 techinical replicas; 
B.Dynamic of DNA demethylation in Lsh off/+ and Lsh off/off  ESCs treated with G9a/GLP inhibitor (+UNC). 
The fold change in 5meC is shown relative to D0.
C.Dynamic of the de novo methylation wave in Lsh off/+ and Lsh off/off  ESCs treated with G9a/GLP inhibitor 
(+UNC). The fold change in 5meC is shown relative to D16 in 2i.
Error bars represent the standart deviation between technical replicas. The percentage of methylated 
cytosine was calculated as percentage of the total cytosine present in the genome analysed. 
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4.5. The absence of LSH promotes chromatin accessibility 
 
The experiments conducted so far demonstrated that cells lacking LSH are 
characterised by misregulation of the 5meC and the 5hmeC in the genome. To explain 
this, the facultative heterochromatin was depleted by inhibition of the G9a/GLP 
methyltransferases complex. The data collected suggests that the activity of LSH might be 
linked to the accessibility of the chromatin and therefore that the protein might be crucial 
for DNA methylation in regions marked by histone modifications, such as H3K9me2. 
Therefore, the absence of LSH might lead to a more open state of the chromatin. 
However, no evidence was yet produced to support this hypothesis.  
In order to examine the state of the chromatin, Micrococcal nuclease (MNase) was 
used to digest the chromatin of Lshoff/off and Lshoff/+ ESCs. This endonuclease cuts 
exposed DNA between nucleosome and is used to infer information on nucleosome 
positioning and the overall chromatin accessibility. After digestion, the DNA associated to 
the nucleosomes is recovered and analysed. Digestion of nuclei with MNAse determines 
formation of mono-nucleosomes. However, depending on the accessibility of the 
chromatin, the formation of mono-nucleosomes requires long, if the chromatin is not 
accessible, or short time, if the chromatin is accessible (Figure 4.6). 
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Figure 4.6.Chromatin accessibility assay 
Schematic representation of the experimental design. Chromatin extracted from Lsh off/+ and Lsh off/off  ESCs 
was digested with the Micrococcal nuclease for 0 minutes (control) to 12 minutes and then DNA was 
extracted and analysed by gel electrophoresis. When the chromatin is compacted (left) and thereby difficult
to access for the MNAse, longer time is necessary to produce di and mono-nucleosomes. On the other 
hand, accessible chromatin is easly digested by the MNAse, hence after very short incubation time 
mononucleosomes are produced. 
  


















To verify it absence of LSH is associated with change in chromatin accessibility, 
nucleosome positioning in Lshoff/off and Lshoff/+ ESCs at day 0, day 2 serum after 16 days in 
2i medium and in Lshoff/off and Lshoff/+ EBs was analysed. After extraction of nuclei, these 
were treated with MNAse for 0 to 12 minutes. Subsequently to nucleosome-associated 
DNA extraction and purification, electrophoresis on agarose gel was used to determine the 
size of the digestion products. Although amount of chromatin was estimated by measuring 
the optical density ratio at 260/280 nm, the results were semi-quantitative and gave an 
indication of the state of chromatin in different samples. At day 0, when the difference in 
DNA methylation between the two genotypes is minimum, the digestion pattern of 
chromatin was similar, indicating that mono-nucleosomes are formed in similar times in 
Lshoff/+ and Lshoff/off ESCs (Figure 4.7A). Similarly, at day 2 in serum-containing medium, 
following 16 days in 2i-containing medium, mono-nucleosomes in the two cell lines are 
formed in equal time (Figure 4.7A). However, the signal intensity profile analysis of 
samples digested for 3 minutes highlighted a difference (Figure 4.7B). In fact, the Lshoff/+ 
ESCs sample was characterised by accumulation of high molecular weight DNA, 
represented by a very sharp peak at the top of the lane. This indicates that not all 
chromatin was digested at that time point of the experiment. However, the Lshoff/off ESCs 
sample showed a broader peak of high molecular weight and presence of low molecular 
weight at the tail of the curve, corresponding to di and mono-nucleosomes. This suggests 
that the digestion of the Lshoff/off ESCs chromatin had started already after 3 minutes of 
incubation with the enzyme (Figure 4.7B). Finally, a more visually obvious difference was 
observed at the EBs stage. In fact, the chromatin of the Lshoff/off EBs was largely digested 
after 3 minutes of incubation with the MNAse, while this was not the case for the Lshoff/+ 
EBs (Figure 4.7). 
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Figure 4.7.Absence of LSH determines increased chromatin accessibility 
A.MNAse digestion assay in Lsh off/+ and Lsh off/off  ESCs at various time points (annotated on the right) in 
the time course experiment. Chromatin was analysed after 3, 6, 9 and 12 minutes of digestion with the 
enzyme. The 0 minutes lane correspond to the treated control, without incubation.
B.Plot of the lane profile of Lsh off/+ and Lsh off/off  ESCs Day 2 Serum and Day 8 EBs, after 3 minutes of 
































These results support the hypothesis that the absence of LSH leads to a more 
accessible chromatin structure. Importantly, the biggest differences are evident after the 
demethylation/de novo methylation phases. Therefore, the absence of LSH alone is not 
enough to determine sever effects in ESC genome architecture. When cells go through 
methylation reprogramming and differentiate, therefore establishing a less dynamic and 






It is difficult to study the DNA methylation dynamics in vivo, at early stage of 
development, due to technical limitations and the difficulties of working with animals. 
However, using 2i-containing medium to culture ESCs recreates the naïve state of 
pluripotency that resembles day 3.5 of the embryonic development. At this stage, the de 
novo methyltransferases are not active either in the embryo or in the 2i-medium cultured 
cells. The subsequent switch in culturing medium enables reactivation of the de novo 
methyltransferases and recapitulates DNA methylation events taking place in the post 
implantation blastocyst. This system, although not perfectly representative of the real 
embryonic development, mimics these early phases and can be used to provide insights 
into the role of LSH at these stages.  
The study of the DNA methylation dynamics in the absence of LSH (Figure 4.2A) 
showed that, when cells had never gone through DNA methylation reprogramming, there 
is no significant difference in the 5meC levels between Lshoff/off and Lshoff/+ ESCs. This 
suggests that cells can maintain the 5meC without LSH, if they are not subject to any 
demethylation or de novo DNA methylation. At later time points of the experiment, ESCs 
lacking LSH lose more 5meC in 2i-containing medium than the heterozygous cells and 
accumulate 5hmeC (Figure 4.3 A). This suggests that although LSH is not involved in 
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maintenance of DNA methylation, it might contribute to the protection of some loci from 
the activity of the TET enzymes. Moreover, the de novo methylation can proceed in the 
absence of LSH (Figure 4.2 A). However, it is incomplete or slower compared to the 
heterozygous control cells. In fact, after 4 days in serum-containing medium the 5meC is 
not completely restored, even though the de novo methyltransferase act faster, possibly 
due to a more open state of the chromatin (Figure 4.2 B and C). Finally, Lshoff/off EBs at 
day 8 of differentiation show a lower level of DNA methylation compared to their 
heterozygous counterparts. This difference is more pronounced compared to the 
difference detected at day 0 of the time course between the two cell lines. Therefore, this 
indicated that LSH has a role concomitant with the de novo methylation and it might be 
important only for methylation of a subset of loci in the genome.  
Overall, the dynamics of DNA methylation (Figure 4.2 B and C), are 2-fold faster in 
absence of LSH than in the control heterozygous for LSH cells. Also, when analysing the 
cells grown with the G9a/GLP inhibitor, the DNA methylation dynamic is more rapid in 
Lshoff/off ESCs compared to Lshoff/+ ESCs (Figure 4.5 B and C). Therefore, when LSH is not 
present, the chromatin is more open and accessible (Figure 4.5 A and B), and this 
promotes the access of DNA for demethylases and methyltransferases. Thus, it can be 
hypothesized that this enhanced accessibility promotes faster DNA methylation dynamics.  
Furthermore, the additive effect of the inhibition of the G9a/GLP complex on top of LSH 
deficiency highlights a possible interplay between LSH and G9a in DNA and histone 
methylation early in embryonic development. More specifically, this might indicate the 
existence of a two step process in the deposition of the methylation: an early one, that is 
not dependent on LSH and G9a and a later one, leading to differentiation of the cells, that 
requires LSH and also G9a. 
So far, this thesis work describes whole genome analyses which were performed to 
elucidate the role of LSH activity early in development. As mentioned above, only a subset 
of the genome seems to require LSH to be correctly methylated. Despite many studies 
have been published showing LSH activity on specific loci, using this culturing system can 
provide a further understanding of the importance of LSH linked to different stages of the 
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early development. In particular, experiments described in the next chapter will investigate 
which are the hypomethylated regions in ESCs that did not go through DNA methylation 
reprogramming (Lshoff/off and Lshoff/+ ESCs at day 0), ESCs that exit the naïve pluripotency 
and had started the de novo methylation wave (Lshoff/off and Lshoff/+ ESCs at day 4 in 
serum, after maintenance in 2i-containing medium) and in cells at early phases of 














Experiments performed so far have shown the importance of LSH for de novo DNA 
methylation, highlighting the role of the protein concomitantly with the reprogramming of 
the 5meC within a system mimicking early phases of the mammalian development. 
Furthermore, I showed that DNA methylation only at a subset of the genome is influenced 
by the presence of LSH. However, the use of HPLC to analyse the amount of DNA 
methylation only provided limited quantitative information and did not allow the 
identification of the genomic regions at which DNA methylation is misregulated in Lshoff/off 
cells concomitantly with DNA methylation reprogramming.  
High-throughput sequencing analyses are a formidable tool to study in detail 
changes occurring at the genome level, by at the same time zooming in and looking at a 
whole genome level. In order to determine which loci require LSH to establish the correct 
DNA methylation patterns after depletion of the modification, we decided to use a high 
throughput sequencing technique called BioCAP-sequencing. By sequencing the 
unmethylated fraction of the genome, this approach will provide insights into which regions 
of the genome are depleted of 5meC and how these change when the genome goes 
through DNA methylation reprogramming. Altogether, this information will help elucidate 






5.2. BioCAP-sequencing is an efficient method to analyse the methylation 
state of the genome.  
 
There are currently many next-generations sequencing technologies that enable 
analysis of the genome methylation state, such as sequencing of bisulfite converted DNA 
(whole genome bisulfite sequencing and reduced representation bisulfite sequencing) or 
sequencing of immunoprecipitated methylated DNA, such as the MeDIP-seq. A relatively 
less common technique is the Biotinylated CxxC affinity Purification-sequencing (BioCAP-
seq). This technique is based on the CxxC Affinity Purification (CAP) approach that uses 
the high affinity of the ZINC finger CxxC protein domain for unmethylated cytosines to 
profile non-methylated DNA (Illingworth et al., 2008). This technique was further optimised 
in Rob Klose’s lab (Blackledge et al., 2012), leading to the use of smaller amounts of input 
DNA and not requiring high-resolution chromatography systems. The BioCAP-sequencing 
uses a biotinylated CxxC peptide, derived from the lysine demethylase KDM2B, bound to 
neutravidin beads (Figure 5.1). These CxxC coated beads are then incubated with 
sonicated genomic DNA, which is then eluted in gradient salt wash. As a result, the eluted 
DNA is enriched in unmethylated cytosines and can be then used for massively parallel 
sequencing. The big advantage of using this technique derives from the fact that 
unmethylated cytosines are only 1-2% of total cytosines in a mammalian genome, 
primarily at CpG islands, especially in differentiated cells or primed pluripotent stem cells, 
such as the mESCs cultured in serum-containing medium. This specific enrichment allows 
deep sequencing with a smaller number of reads required for coverage compared to 
whole genome sequencing techniques. Therefore, this method, albeit indirectly, provides 




The crucial step in the BioCAP technique is the pull down of the unmethylated 
fraction of the genome, using CxxC coated neutravidin beads. To ensure sequencing of 
only the highly unmethylated fraction of the genome, after a first step of incubation of the 
coated beads with sonicated whole gDNA, these were washed in buffers with increasing 
salt concentration, from 100 to 1000 mM NaCl (Figure 5.1). To verify that the CxxC coated 
beads were highly specific for binding to unmethylated DNA, PCR analyses were 
performed after each washing step (Figure 5.2). Three genes were chosen for this 
analysis, 2 of which, Actin B and Moesin (Msn), were predicted to be unmethylated at the 
promoter and therefore expected to elute from the beads only in high salt buffers. The 
third locus chosen was the Fatty Acid Binding Protein 7, Fabp7, predicted to be 
methylated in mESCs and hence expected to elute from the beads in low salt buffer 
washes. The presence of Actin B and Msn DNA in fractions with 700mM and 1000mM 
NaCl confirmed that these regions bind to the CxxC coated bead with higher affinity than it 
could be expected from unmethylated regions and hence could be eluted from the beads 
only in presence of high concentration of salts (Figure 5.2, top panel). On the contrary, the 
presence of Fabp7 DNA at low NaCl concentration (Figure 5.2, bottom panel) showed that 
this sequence of DNA could be easily eluted from the beads, indicating low affinity binding 
presumably due to the high cytosine methylation level.  
These preliminary results tested the reliability of the coated beads produced in the 
Stancheva lab by Dani Wickacsono and proved that they are suitable for further 
experiments. Therefore, we decided to proceed with the high throughput sequencing 
experiment, to investigate which regions of the genome require LSH for deposition of DNA 
methylation.  
In order to address this question, the methylation status of Lshoff/+ and Lshoff/off 
mESCs at day 0, cultured in serum-containing medium, were analysed by BioCAP-
sequencing as control time point. Lshoff/+ and Lshoff/off mESCs cultured in serum for 4 days 
after 16 days in 2i-containing medium were collected and DNA was analysed to investigate 
the changes occurring right after the demethylation, caused by treatment with 2i. Finally, 
DNA of Lshoff/+ and Lshoff/off EBs at 8 days of growth was sequenced to consider how 
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absence of LSH could impact changes in 5meC of cells beginning the differentiation 
process. Sequencing of these samples will provide insights into which loci are 
hypomethylated in the absence of LSH. Furthermore, the comparison of samples at 
different time points of the time course experiment, that mimics the early stages of mouse 
embryonic development, will help understanding the timing of LSH activity. In fact, by 
analysing the difference in DNA methylation between day 0 and the subsequent time 
points, it should be possible to determine which regions become methylation-depleted as 
a consequence of the methylation reprogramming events, namely the demethylation 
wave, the activation of de novo DNA methyltransferases and finally a second de novo 





Figure 5.2 Optimisation of biotinylated CxxC affinity purification (BioCAP).
PCR analyses of the different fractions derived by the elution of gDNA from neutravidin-CxxC beads. ActinB, 
Msn and Fabp7 have CpG-rich promoter regions and were selected as unmethylated examples. Fabp7
promoter is known to be methylated in mESCs. As predicted, ActinB and Msn are enriched in fractions 
eluted with high salt (top panel). On the contrary, Fabp7 is enriched in fractions eluted with low salt, reflecting




































5.3. BioCAP-sequencing identifies loci characterised by LSH-dependent 
methylation. 
 
Various studies have investigated the role of LSH at specific loci (Dennis et al., 
2001; Fan, 2005; Myant et al., 2011; Xi et al., 2007). However, these studies provided 
insights into a static system, showing which specific genes are hypomethylated in the 
absence of LSH in a specific developmental stage or cell type. Combining BioCAP-
sequencing and the culturing system set up in this study should provide not only 
information about the regions of the genome that are hypomethylated in absence of LSH 
at different stages, but also about the dynamics of these changes over time, depending on 
the regulatory processes within the cell.  
High quality sequencing results (Appendix table 1 and figure 1) were analysed by 
mapping the reads to the mouse genome (Figure 5.1). Differentially methylated peaks in 
the Lshoff/off samples were identified by comparing reads found to the Lshoff/+ controls to 
those found in samples lacking LSH, using the diffBind tool (Figure 5.3). At day 0, before 
any type of regulation of the DNA methylation is initiated by changes in culturing 
conditions, there was a small subset of peaks that corresponded to sequences 
hypomethylated in absence of LSH when compared to the control Lshoff+f ESCs (Figure 
5.3, in red). This result is consistent with the previously described HPLC analyses (Figure 
4.2). Interestingly, some hypermethylation was also detected at this time point (Figure 5.3, 
in blue), suggesting a mechanism of redistribution of the modification, including loss and 
acquisition of methylation at some loci in the LSH depleted cells. Subsequent culturing in 
2i-containing medium leads to depletion of DNA methylation and inactivation of de novo 
methyltransferases. This step is then followed by the reactivation of the de novo 
methylation machinery caused by the culturing of the cells in serum. The sequencing at 
this point showed a larger number of peaks in Lshoff/off ESCs differentially methylated 
compared to the control cell line, almost 5000 peaks more than at day 0 (Figure 5.3). As 
seen in the HPLC analysis (Figure 4.2), after depletion of 5meC there is a recovery time 
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before acquisition of the 5meC to levels comparable to day 0 and this time is apparently 
longer for LSH depleted cells. Therefore, accumulation of hypomethylated regions in the 
genome in cells cultured for 2 days in serum was consistent with what expected. 
Interestingly, at the EBs stage, the last time point of the experimental system, there were 
still some differentially methylated regions in absence of LSH. Despite the absence of 
regions that accumulated 5meC, there were still hypomethylated regions in the Lshoff/off 
EBs compared to the control cell line (Figure 5.3, in red). The total number of peaks 
mapping at differentially methylated regions in Lshoff/off EBs decreases comparing to day 2 
in serum, but there was still an enrichment compared to day 0. The overall dynamic of 
change in 5meC is similar to what was shown by HPLC in chapter 4. In fact, at the same 
time point a difference in the percentage of 5meC between the two genotypes was 
detected. As mentioned before, this indicates that de novo methylation can occur in 
absence of LSH, but it might be less efficient or slower. Furthermore, the decrease in the 
number of differentially methylated regions might indicate that a subset of loci can get 
methylated and some others cannot. However, it cannot be excluded that all the loci found 
hypomethylated in the absence of LSH at day 2 in serum-containing medium gain 
methylation and then, concomitantly with the beginning of differentiation, some loci cannot 
correctly retain methylation and therefore are found unmethylated in EBs, while in the 
control EBs the same loci are stably methylated.  
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Figure 5.3 Differentially methylated peak analysis shows accumulation of methylation depleted 
genomic regions at day 2 serum and EBs.
The total number of peaks mapping to differentially methylated regions found in Lshoff/off ESCs or EBs 
after comparison to Lshoff/+ ESCs or EBs at the 3 time points of the time course experiment analysed by 
BioCap-seq are shown on the x axis. Positive log2 fold change values indicate overrepresented DNA 
sequences, hence unmethylated regions and are represented in red. Negative log2FC values indicate  
under represented sequences and therefore hypermethilated genomic regions and are represented in blue. 
While there is not a big number of peaks mapping to hypomethylated loci at day 0, the enrichment becomes
apparent when the ESCs are recovering from 2i-induced demethylation followed by differentiation. The 
enrichment in number of  peaks decreases at the EBs stage, but remains higher than at day 0. 
False Discovery Rate <0.05.
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To distinguish between the hypothesis that a subset of loci requires LSH for being 
correctly methylated during the first wave of de novo methylation and remain 
hypomethylated until the EB stage or that loci hypomethylated in EBs lacking LSH differ 
from those found at day 2 in serum, the BioCAP-sequencing was a great tool.  
The first step into analysing in details the regions of the genome hypomethylated in 
LSH depleted cells was determining the distribution of the differentially methylated peaks 
throughout the genome. Therefore, the genome was divided into features, as indicated in 
figure 5.4, and both the peaks found in hypomethylated and hypermethyalted regions 
(Figure 5.3) were assigned to a feature of the genome. While the majority of loci that 
acquire methylation represented promoter regions, interestingly most of the 
hypomethylated regions mapped to distal intergenic regions (Figure 5.4). More 
specifically, the percentage of peaks mapping to distal intergenic regions in cells lacking 
LSH increased from approximately 20% at day 0 to 70% day 8 of EBs formation. This 
suggests that the effect of the absence of LSH detected at the EBs stage might be mostly 
caused by hypomethylation of these distal intergenic regions, which include repetitive 
elements. Moreover, the percentage of hypomethylated peaks localising at promoter 
regions decreased from almost 40% at day 0 to about 10% day 2 in serum and remained 
stable at day 8 of EBs development. Bearing in mind the way smaller number of peaks 
that were differentially methylated between Lshoff/off and Lshoff/+ ESCs at day 0, it is 
noticeable that this percentage decreased drastically, but then remained consistent 
between day 2 in serum and day 8 EBs. This might indicate that the promoters that do not 
gain methylation at day 2 in serum remain unmethylated at the stage of EBs and might be 
specific targets of LSH activity. However, it remains unclear at this point if these loci are 
the same at the two time points and therefore further analyses are necessary.  
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Figure 5.4 Feature distribution of differentially methylated regions found in Lshoff/off samples.  
Loci identified in the differential peaks analysis were categorised based on their location in the genome. 
These 11 categories, also referred to as features, are listed on the right, together with the colour assiged to 
each. Percentage of peaks falling into each category for every time point is shown, for loci depleted of 
methylation and enriched in methylation. The hypomethylated peaks fall mostly into the category of distal 
intergenic regions at day 2 in serum and day 8 EBs. On the other hand, the methylated peaks are mostly 
localised at promoter regions at day 2 in serum and day 8 of EBs.     
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These experiments provide first of all evidence for the reliability of the method used 
for sequencing due to the consistency with the analysis performed by HPLC and 
discussed in previous chapters. Furthermore, these experiments show that the 
hypomethylated regions of the genome in LSH-deficient cells represent mainly distal 
intergenic regions, but this approach did not provide detailed information on the specific 
regions involved. Interestingly, some promoter regions are found unmethylated in absence 
of LSH, supporting the hypothesis that LSH is important for methylation of the cytosine, 
not only at repetitive elements, but also at unique genomic regions, including promoters. 
Further analyses will address the question of which promoters are hypomethylated in the 
absence of LSH and, importantly, if these remain the same after the demethylation stage 
at day 2 in serum up to the EBs formation or not.  
Finally, BioCAP-sequencing analysis result support HPLC data, highlighting a time 
frame of activity of LSH, as the hypomethylation appears massively after the 
demethylation wave, induced by the treatment with 2i, and remains evident until the EBs 
stage. It will be important to identify the specific genes and distal intergenic regions that 
are demethylated in the absence of LSH in order to understand if these genes are 
depleted of 5meC and maintained so through the time course experiment, suggesting that 
LSH might be necessary to methylate these regions in vivo during development after the 
first reprogramming of the 5meC. Or if, alternatively, the genomic regions involved change 
after the activation of the de novo methylation machinery and the subsequent 
differentiation, suggesting that 5meC loss in absence of LSH can be overcame first and 




5.4. LSH is required for methylation at non-repetitive sequences 
 
After looking at the distribution of differentially methylated regions in the genome of 
Lshoff/off cells, two main regions of interested emerged: distal intergenic regions, for their 
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abundance of differentially methylated peaks, and promoter regions, for the consistent 
percentage at day 2 serum and day 8 EBs. As previously shown by various studies 
(Dennis et al., 2001; Fan, 2005; Myant et al., 2011; Xi et al., 2007), LSH is required for 
methylation at specific unique loci, such as the Rhox genes and Gm9 in MEFs. Therefore, 
further characterisation of genes with demethylated regions was performed.  
We first looked at the Gene Ontology terms in which the regions of differential 
methylation could be categorised into (Figure 5.5). Comparison between Lshoff/off and 
Lshoff/+ cells allowed to infer the most frequent terms describing the differential peaks. 
Interestingly, of the 3 categories, namely biological processes, cellular components and 
molecular function, at day 0 70% of the small number of differentially methylated genes 
identified belong to the biological process category, but this percentage decreased during 
the time course experiment (Figure 5.5). In fact, at day 2 in serum, 65% of the genes were 
categorised in the biological process category and at day 8 EBs this dropped to 50%. The 
decrease in genes related to this category was accompanied by an increase in the number 
of differentially methylated genes that were included in the cellular components or 
molecular function category from 10% and 15%, respectively, at day 0 to 27% and 22% at 
day 8 EBs (Figure 5.5). This change in the categorisation of the Gene Ontology terms 
suggests a shift in the regions of the genome hypomethylated in absence of LSH and 
might indicate a specificity of the protein towards some regions of the genome, arising 






The GO categories falling into the 3 broader terms are listed in Figure 5.6. The most 
important feature to highlight is that there is a slow transition beginning at day 0 and 
moving towards day 8 EBs into terms more and more specific for neuronal specialisations. 
More specifically, while the categories coming up from the analysis at day 0 are more 
general, such as metabolism, cell and protein binding, or focused on the embryo 
development, such as embryonic morphogenesis or developmental process, and only 
some terms concern the neuronal lineage, such as synapsis, these change already when 
cells come out of the demethylation wave at day 2 in serum, and is even more pronounced 
at the EBs stage (Figure 5.6). Expression of these genes at day 8 EBs is expected, due to 
the addition after 4 days in culture of retinoic acid, which drives EBs towards neuronal 
lineage. Interestingly, however, almost all the terms describing hypomethylated regions 
Figure 5.6 Gene Ontology analysis of hypomethylated genes shows differences in the distribution of 
GO terms over time. 
Pie charts representing the percentage of hypomethylated genes described by each GO category at each
time point of the experiment. The  percentage of hypomethylated loci involved in formation of cellular 
components increases over the time course experiment. The time point in the experiment are shown on top of
















specifically in absence of LSH are connected to neuronal development or chemical activity 
of the nervous system. On one hand this result shows that the regions depleted of 5meC 
in absence of LSH partially differ depending on the developmental stage and, on the other 
hand, it suggests that LSH activity might be bound to the neuronal lineage. This feature 
becomes evident only later in the time point experiment because these are regions of the 
genome regulated only when cell differentiation is activated. If the methylation does not 
occur correctly at these regions, this might lead to impaired differentiation towards the 




To characterise further the peaks that map across promoter regions, we decided to 
ask whether the differentially methylated regions in Lshoff/off samples compared to Lshoff/+ 
were the same at day 2 in serum and day 8 EBs. Over the total number of peaks mapping 
to these regions of the genome at the two time points, around 1000 are found in both 
samples. Of these genes, 77% are protein coding (Figure 5.7A). These genes were then 
analysed to explore the GO terms and it was found that around half of these genes belong 
to the biological process category (Figure 5.7B). This category distribution is very similar 
to what detected in day 8 EBs (Figure 5.5). When analysing the categorisations within the 
3 aspects, biological processes, cellular components and molecular function (Figure 5.7 
C), once again it seems that most of the genes fell into categories related to the nervous 
system, similarly to what was observed in the previous analysis (Figure 5.6). Altogether, 
these data show that there is a fraction of promoters that in absence of LSH are not 
methylated at day 2 in serum and they are kept in this state until the last time point of the 
experiment.  
The characterisation of differentially methylated peaks identified by BioCAP-
sequencing provided insights into the functions of the genes that are found 
hypomethylated in absence of LSH. What became evident from the changes in GO 
categories distribution following the regulations of 5meC during the time course 
experiments is that there is a gradual increase in the number of terms related to neuronal 
system. This was expected in the EBs samples, in both genotype, as the addition of 
retinoic acid is used to trigger differentiation into neuronal linage. However, comparing the 
differentially methylated peaks mapping at promoter regions at day 2 in serum and day 8 
EBs, clarified that there is a subgroup of promoters that are already hypomethylated at 
day 2 in serum in absence of LSH and that these promoters do not acquire 5meC by the 
time the EBs are formed, at day 8. This, together with the presence of promoter regions 
that can gain methylation and others that lose it, suggests that there are some loci that 
might be the main targets for regulation by LSH as these promoters are unable to gain 
methylation in the absence of the protein, once it is lost. At the same time, there are other 
regions that can gain DNA methylation, but possibly require longer time compared to other 
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regions, despite the generally more accessible state of the chromatin in cells lacking LSH. 
Finally, when the cells go through differentiation, mimicking what happens in the embryo 
after E6.5, some genomic regions are not capable of acquiring 5meC, as suggest by the 
emerging at day 8 EBs of GO category terms related to the nervous system. Altogether, 
this suggests the potential existence of different sets of targets, the first requiring LSH for 
de novo methylation at the formation of the blastocyst and the second requiring LSH at the 
epiblast stage. However, it remains unclear what determines the need for LSH at those 
specific loci and what triggers its activity during the two main regulatory events of DNA 




5.5. LSH is crucial for methylation of IAPs, a subfamily of repetitive 
elements, early in development.  
 
From the feature distribution analysis, it emerged that the highest percentage of 
differentially methylated peaks map at distal intergenic regions. Within this feature, many 
genomic regions could be accounted, such as noncoding DNA, regulatory regions, 
enhancers, noncoding RNAs and repetitive elements. Since it was previously shown that 
LSH is necessary for the regulation of DNA methylation at repetitive elements (De La 
Fuente et al., 2006; Huang et al., 2004), and especially at endogenous mouse 
retrotransposons IAPs (intracisternal A-particle), we decided to focus our attention on 
these retroviral elements. Doing so, will provide, not only validation for the method used, 
but also further insights into which repetitive elements, other than IAPs, are 
hypomethylated in the absence of LSH, and what is the time frame for this regulation. 
Such information is crucial information to better understand the consequences of LSH 
KOs in mouse development.  
Repetitive elements (RE) contained in heterochromatic regions are derived from 
transposable elements and make up around half of the mammalian genome (45% in 
human, (Lander et al., 2001). There are 2 main classes of repetitive elements, the first 
includes retrotransposons that produce reverse transcriptase, similarly to retroviruses, and 
is the most abundant. The second class include DNA transposons, are not active in the 
mouse and human genomes and are about 3% of the genome (Lander et al., 2001). 
These elements can be silenced by various post translational modifications and DNA 
methylation. It is crucial to understand the mechanism leading to repression of these very 
abundant elements in the genome, as it has been shown that reexpression of these is 
associated with diseases, such as cancer, and with a more sever outcome in those 
instances (Nguyen et al., 2018). 
Retrotransposons fall into 2 categories, those characterised by long terminal repeats 
(LTR), such as the endogenous retroviral elements ERV, that account for about 10% of 
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the mouse genome (Lander et al., 2001). Belonging to the ERVK class are also the IAPs 
elements, retroviral elements containing 2 LTR at each end of the sequence, which can 
drive expression in cancer such as lymphoma (Lane et al., 2003; Qin et al., 2010). The 
second class of RE is characterised by the absence of LTRs and includes long 
interspersed elements (LINE) and short interspersed elements (SINE).  
As mention in the introduction of this thesis, LSH activity has been linked to the 
expression of repetitive elements, such as LTRs in brain and liver tissue of KO mice for 
Lsh (Huang et al., 2004) and IAPs in oocytes and mouse embryonic fibroblasts (De La 
Fuente et al., 2006; Myant et al., 2011). Therefore, we analysed the differentially 
methylated regions in Lshoff/off cells compared to Lshoff/+ cells at various time points in the 
time course experiment and interrogated more specifically the peaks mapping over 
repetitive sequences. More than 50 families of RE were analysed and the peak distribution 
was compared to a random distribution in order to establish a significance for the mapping 
of each of the families. More specifically, among the top 20 families with the highest 
number of mapped hypomethylated reads, only few showed significant enrichment in 
these reads compared to a random distribution (Figure 5.8). At day 0 there are some 
differentially methylated RE, namely Alu elements (member of the non-LTRs) and the 
simple repeats (Figure 5.8, bottom panel). After the cells go through DNA methylation 
reprogramming, there is an expected increase in the number of hypomethylated regions, 
including repetitive elements. In fact, at day 2 in serum, more than 25% of the peaks map 
at ERVK family, comprising the IAPS elements. The second most abundant RE are the 
L1, belonging to the LINE family, and the third are yet the simple repeats (Figure 5.8, 
middle panel). Finally, at day 8 of the EBs development, 46% of the total peaks map at 
ERVK elements and less than 40% to L1 (Figure 5.8, top panel). Altogether, this analysis 
shows that the type of repetitive element hypomethylated in Lshoff/off cells changes after 
the loss of 5meC in 2i-containing medium. Instead of acquiring DNA methylation due to 
the activation of the de novo methylation machinery in serum-containing medium, in 
absence of LSH ERVK and L1 elements specifically stay hypomethylated until the 
formation of the EBs, while the other elements acquire methylation or are not significantly 
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differentially methylated compared to the control. This suggests a LSH-dependent 
methylation mechanism that operates at these repetitive elements initiated after loss of 
5meC. This methylation depletion is not overcome by the de novo methylation, possibly 
impaired by the absence of the protein.  
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Figure 5.8 Families of repetitive elements differentially methylated in the absence of LSH change 
over time. 
Top 20 repetitive element families that are differentially methylated in Lshoff/off compared to Lshoff/+ cells
are shown at day 0, day 2 serum and day 8 EBs. The percentage of peaks that overlap with each repetitive 
element family is shown. Only elements represented by the bars in blue are significantly enriched over a 
random distribution of the reads, with Permutation test p-value <=0.05. The most significantly differentially 
methylated repetitive element families change between day 0 and later time points of the time course 
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To better understand how IAPs methylation status changed through the time course 
experiment in presence and absence of LSH, reads of unmethylated CpG mapping at 
IAPs annotated sequences were analysed. While at day 0 there were virtually no reads 
mapping at IAPs in the genome of both cell lines analysed (Figure 5.9, left panel), at day 2 
in serum there were peaks mapping at both LTRs, as might be expected due to the 
treatment of the mESCs with 2i-containing medium (Figure 5.9, central panel). There was 
however an increase in number of reads mapping at those regions in both biological 
replicas of Lshoff/off ESCs, compared to Lshoff/+ ESCs (Figure 5.9, middle panel). At day 8 
of EBs development, almost no reads mapped at IAPs in Lshoff/+ ESCs, while there were 
still reads mapping at LTRs of the IAPs Lshoff/off EBs, despite a difference in the number of 
peaks between biological replicas (Figure 5.9, right panel). This difference could be 
explained by variability of EBs differentiation compared to mESCs in culture. The 
decrease in the number of reads mapping to IAPs at day 8 EBs compared to day 2 serum 
might suggest that some IAPs can always be methylated, both in Lshoff/off and Lshoff/+ EBs. 
However, there is yet a large proportion of these elements that in absence of LSH do not 
gain methylation. These results are consistent with LSH activity specifically targeting IAPs 
as was shown previously (De La Fuente et al., 2006; Huang et al., 2004). However, our 
experiments show that the hypomethylation of these regions only occurs after depletion of 
DNA methylation by treatment of ESCs with 2 inhibitors and cannot be recovered 
completely, at least in the time frame we investigated. We hypothesise that absence of 
LSH could lead to similar hypomethylation dynamics in vivo, impairing 5meC acquisition 





Misregulation of DNA methylation at IAPs was shown to activate the expression of 
these elements, for example an IAP element inserted into the Agouti locus can be 
activated by chemical treatment and other stimuli leading subsequently to activation of the 
Agouti gene in mice (Lane et al., 2003). Therefore, it was important to analyse the 
expression of these elements in the time course experiment. First, the hypomethylation of 
the elements was validated by bisulfite-sequencing. The analysis of the 5’ UTR with this 
technique showed no difference in DNA methylation between Lshoff/off and Lshoff/+ ESCs at 
day 0, and a subsequent loss of 5meC at day 16 in 2i-containing medium (Figure 5.10A). 
Figure 5.9 IAP elements are hypomethylated in the absence of LSH.
Plot of unique BioCAP reads across annotated IAPEz elements. At each time point, all the samples are shown 
in different colours. On the x axis the distance from the LTRs is annotated. On the y axis is annotated the 
number of reads mapping to that site. Almost no reads map to IAPEz at day 0. At day 2 in serum, these
regions are enriched in reads, in all the samples analised. At day 8 of EBs development, while no reads map 
at these regions in Lshoff/+ EBs, there are still reads mapping at these regions in Lshoff/off EBs, indicating 
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After 4 days in serum post 2i, the difference in 5meC between Lshoff/off and Lshoff/+ ESCs 
became more pronounced. However, this region of the IAPs gained methylation to 
comparable levels in the two cell lines at day 4 of the EBs development (Figure 5.10A). 
Unfortunately, the change in DNA methylation detected with this technique was not 
completely consistent with what was shown by the BioCAP-sequencing. However, it is 
important to highlight that Bisulfite-sequencing PCR only analysed the methylation of a 
specific and limited set of CpGs, compared to sequencing techniques that provide 
information on the whole sequence. Moreover, when analysing the expression of the IAPs 
by qRT-PCR (Figure 5.10B), an increase in the expression of IAPs was detected in both 
genotypes at day 2 in serum, as expected after treatment with the 2 inhibitors. Expression 
was even higher at day 8 of EBs, especially in cells lacking LSH. Furthermore, at both 
time points of the experiment, the expression of IAPs relative to day 0 was higher in 
Lshoff/off samples, consistent with BioCAP-sequencing results. The increase in the 
expression at day 8 in both Lshoff/off and Lshoff/+ EBs, despite a decrease in the DNA 
methylation might be dependent on an accumulation of IAP mRNA produced during 
previous stages of the experimental system and not completely degraded yet. Despite 
difference in expression of IAPs between Lshoff/off and Lshoff/+ samples not being 
statistically significant, it suggests that the hypomethylation of IAPs leads to expression of 
these elements, in both Lshoff/off and Lshoff/+ EBs, but to be a bigger extent in Lshoff/off EBs. 
It is not possible to conclude whether the difference in expression between cells with the 
two genotypes could lead to specific consequences for cell differentiation in the absence 
of LSH. It is however important to highlight that expression of these RE is initiated only 
after the depletion of DNA methylation and is more prominent in cells lacking LSH, 
highlighting a LSH dependent mechanism for the 5meC deposition at these sequences 







Figure 5.10 The IAP elements are hypomethylated in the absence of LSH and differentially expressed.
A.Bisulfite sequencing analysis of the 5’LTR of IAP elements shows loss of methylation at this end of the 
element and a slow recovery of DNA methylation in serum and EBs.
B.Quantitative RT-PCR detects expression of IAPS at day 4 in serum post 2i and in day 8 EBs, relative to 
day 0. GAPDH was used as internal control. Error bars represent standard deviation between mean values.
The expression of IAPs increases at every step of the time course, consistantly with the depletion of 5meC. 
The increase in expression is higher in Lshoff/off EBs compared to the Lshoff/+ control, despite the detected 










































Experiments described in previous chapters showed that LSH is required for de 
novo methylation throughout the genome, consistently with work previously published 
(Myant & Stancheva, 2008; Dunican et al., 2013; He et al., 2016; Jiang et al., 2017; Joshi 
et al., 2011; Myant et al., 2011), and suggest a time frame in which the role of LSH 
becomes relevant for the regulation of DNA methylation. In this last chapter, I used a high 
throughput sequencing technique to explore whether the absence of LSH influenced the 
methylation of specific genomic loci, i.e. genomic features. Identification of differentially 
methylated regions in Lshoff/off cells compared to Lshoff/+ cells showed that, subsequently to 
the depletion of 5meC induced by culturing the cells in 2i medium, during the methylation 
recovery phase and the differentiation, the absence of LSH leads to demethylation of 
distal intergenic regions, promoter regions and gene bodies. When we interrogated genes 
and promoters depleted of 5meC, we found that only about 10% of promoter regions are 
hypomethylated at day 2 serum and day 8 EBs. As expected, most of the promoters are 
hypomethyalted only transiently at day 2 in serum, since at this time point of the 
experiment deposition of methyl groups has just been triggered by the change in culturing 
medium. This suggests the existence of two phases in the DNA methylation deposition in 
the absence of LSH. In the first phase, some genes acquire 5meC when de novo 
methylation machinery is activated, but require more time to be fully methylated compared 
to Lshoff/+ cells, consistent with the deeper loss of methylation in 2i-containing medium 
occurring in LSH deficient cells possibly due to the increased accessibility of chromatin to 
demethylases enzymes. Later on in the time course experiment, when differentiation is 
triggered by addition of RA to the culture, a new phase of regulation of DNA methylation 
starts. At the EBs stage, in fact, most of the hypomethylated genes in Lshoff/off cells were 
categorised by GO terms related to the nervous system development or regulation. Since 
in the experimental design, the EBs were taken through the first steps of the differentiation 
into the neuronal lineage by addition of retinoic acid and withdrawal of LIF, this supports 
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previous findings in neural stem progenitor cells (Han et al., 2017) that LSH might be 
crucial for the correct regulation of DNA methylation and possibly the expression of those 
genes. A small number of promoter regions are hypomethylated immediately after the 
recovery from 2i-medium occurs, and these remain hypomethylated throughout EB 
formation and differentiation. These genes might be the main, direct or indirect, targets of 
LSH and are in fact associated to the neuronal lineage differentiation path. This might 
indicate that those genes are particularly sensitive to the absence of LSH and may not be 
correctly methylated early in the embryonic development, leading to misregulation of gene 
expression in the later differentiation stage. Further analysis of the expression of these 
genes in our cell culturing system and then in vivo would provide further insights into the 
consequences of the loss of DNA methylation in cells lacking LSH and whether this is 
relevant to embryonic development.  
Consistently with what was previously shown (De La Fuente et al., 2006; Huang et 
al., 2004; Myant et al., 2011), distal intergenic regions and more specifically RE were 
found hypomethylated in LSH depleted cells. These regions, very much like the neuronal 
genes discussed above, are methylation depleted at day 2 in serum post 2i and remain 
hypomethylated in the EBs. ERVK and LINE1 elements were the main hypomethylated 
elements in cells lacking LSH after treatment with 2i, and IAPs in particular were further 
analysed and were not only hypomethylated, but also expressed immediately after 
recovery from 2i medium and in day 8 EBs lacking LSH. These results are consistent with 
what was reported in literature in different cell models, indicating that these regions require 
LSH to regulate the methylation of the DNA probably at the exit of naïve state of 
pluripotency of the cells.  
Altogether, the data described in this chapter show that LSH is dispensable for 
methylation of the majority of the genome sequenced with the BioCAP-sequencing 
approach, but required for methylation of neuronal associated genes and repetitive 
elements. Importantly, this role emerges in vitro always after the demethylation caused by 
culturing the cells with 2i and seems crucial for the regulation of the DNA methylation in 
embryonic bodies. Therefore, it is possible to hypothesise that in vivo LSH might be 
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required at specific genomic regions after blastocyst formation at day E3.5 of the mouse 



































Despite the big efforts which led to the publications of many studies on LSH activity 
in mammals, there is yet a lot to uncover. It has been very recently proven LSH’s activity 
in remodelling chromatin, as a member of a remodelling complex with CDCA7 (Jenness et 
al., 2018). A role for the protein was shown in de novo methylation of DNA but it is yet 
unclear whether it has a role in maintenance of DNA methylation, too. It was shown that 
absence of the protein determines defects in the DNA methylation in MEFs, oocytes and 
embryos after day 12.5 of the development. However, no information on earlier 
developmental stages nor on the molecular mechanism by which the protein modulates 
DNA methylation throughout development are available. This study was aimed at 
addressing whether LSH is involved in DNA methylation de novo deposition or in 
maintenance of this epigenetic modification. Furthermore, an in vitro culturing system was 
optimised to attempt understanding when during development the protein becomes pivotal 
for 5meC regulation and which loci in the genome require LSH for achieving correct DNA 
methylation state. This in vitro culturing system used mESCs to mimic early phases of the 
mouse embryonic development, between day E3.5 and E12, and hence facilitated the 
study of DNA methylation dynamics in absence of LSH activity.     
Optimisation of the culturing system was the first step to investigate how 5meC 
levels are affected by absence of LSH in response to reprogramming events. The use of 
medium supplemented with inhibitors for GSK3beta and WNT allowed depletion of DNA 
methylation to a level similar to the blastocyst’s, mimicking at the same time the loss of 
methylation occurring in the paternal and maternal genomes at the beginning of the 
embryonic development (Figure 1.6). Lshoff/off mESCs cultured in this condition show 
bigger loss of 5meC compared to the control cell line. The recovery of the 5meC 
determined by the initiation of de novo methylation in serum-containing medium also is 
affected by lack of LSH. In fact, Lshoff/off mESCs do not recover methylation to a level 
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comparable to the initial, despite accumulating methyl groups in a faster manner. LSH 
being capable of remodelling heterochromatic regions, it is hypothesised that its absence 
may influence the compaction of the chromatin, by making it more accessible. This 
hypothesis was supported by preliminary data obtained by chromatin digestion by MNAse, 
showing a more open chromatin state in cells lacking LSH at day 8 EBs. The accessibility 
of the chromatin should be investigated further, by using a high throughput approach such 
as MNAse-seq at different time points in the time course experiment. Despite not 
predicting sever effects on the chromatin structure of the whole genome, this experiment 
would provide more information into how the chromatin accessibility changes at target 
regions in response to the reprogramming events in absence of LSH and prove its 
importance in compaction of the chromatin.   
The analysis of the intermediate product of oxidation of 5meC to cytosine, 5hmeC, 
provided some evidence to support a role of LSH in de novo methylation and not in 
maintenance of methylation. In fact, if the further loss of 5meC detected in Lshoff/off mESCs 
was accountable to deficiency in the maintenance of methylation, no accumulation of 
5hmeC would be detected. Interestingly, this is not the case. Although this is not enough 
evidence to prove a unique role of LSH in de novo methylation, it is sufficient to say that in 
this instance, maintenance of DNA methylation is not imputable for the differences in 
quantity of methylation lost in 2i-medium culturing conditions. To further investigate how 
absence of LSH determines this increased loss of methylation, analyses of the expression 
of TET1/2 enzymes could be carried out. Some preliminary analysis shows that there is no 
significant difference in the expression of TET1 and TET2 between Lshoff/+  and Lshoff/off 
mESCs (data not shown). To give a definite answer to whether LSH is linked to both de 
novo and maintenance of DNA methylation or exclusively to de novo methylation, Lshoff/off 
ESCs could be maintained in serum containing medium for longer passages and 5meC, 
5hmeC and TET expression could be analysed at different times during the experiment 
and compared to Lshoff/+ ESCs and ESCs depleted of Dnmt1. Direct comparison of the 
behavior of cells lacking the main protein responsible of maintenance of DNA methylation 
with cells lacking LSH could confirm or disproof the hypothesis of LSH being mainly 
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involved in de novo methylation.  
HPLC analysis also showed that at the EBs stage, in absence of LSH 5meC is 
significantly lower compared to the control cell lines. This points toward two possible 
explanations: first, that cells need longer time to recover the 5meC in absence of LSH; 
second, that some loci cannot gain methylation in absence of LSH. Data derived from 
BioCAP-sequencing analysis were interrogated and a subset of genes hypomethylated in 
absence of LSH was identified. These genes lose methylation in 2i and do not gain the 
modification by the end of the experimental time window. A further step of completion of 
the differentiation process could be performed to determine whether the hypomethylation 
of these regions affects the differentiation process. Differentiating the EBs in different cell 
types might also provide information on the specificity of the target of LSH. In fact, Gene 
Ontology analysis showed that majority of the terms describing the genes differentially 
methylated in absence of LSH were related to neuronal system. These terms emerge from 
the analyses of the genes not methylated at day 2 in serum and day 8 EBs, hence 
indicating that it is not necessary any stimulation towards the neuronal lineage 
differentiation, such as retinoic acid addition, for these to be misregulated. This highlight a 
possible specific activity of LSH in this cell type and is consistent with the defects that the 
Lshoff/off mouse produced in the Stancheva lab shows (data not shown). However, this 
should be further investigated. ChIP-qPCR for LSH on a subset of candidate genes could 
be perform to determine the localization of the remodeling complex formed by LSH at 
those loci and therefore allowing to explain the depletion of DNA methylation in its 
absence.  
As previously shown, LSH is important for methylation of DNA at repetitive 
elements, specifically LINE and IAPs. The culturing system used in this study could 
elucidate the time frame in which these repetitive sequences lose methylation in absence 
of LSH. As it happens for the unique loci, it emerges from BioCAP-sequencing analysis 
that the repetitive elements are differentially methylated at the initiation of de novo 
methylation and stay so until the EBs stage. It will be necessary to evaluate the 
expression of these elements and monitor this expression at subsequent differentiation 
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steps, by RNA-sequencing or simple qRT-PCR. Information about the expression status of 
these elements is necessary to fully understand the consequences of absence of LSH 
during embryonic development. In fact, it was shown in human and mouse how 
expression of repetitive elements affect the status not only of the single cell, but of a whole 
organism (Lane et al., 2003; Qin et al., 2010). RNA-sequencing could also provide 
information on the expression of unique loci, hence determining a clearer understanding of 
how lack of methylation is linked to gene expression in absence of LSH. 
Altogether, these data suggest that some regions of the genome, both unique and 
repetitive, require LSH to be methylated at E3.5. Therefore, it can be hypothesised that 
LSH is driven to these loci and assure deposition of methylation by remodeling the 
heterochromatin and allowing access to DNMTs. These loci are therefore silenced. When 
LSH is absent, these genomic regions cannot be remodeler and DNMTs do not have 
access. Therefore, these regions cannot be silenced.  
Importantly, it is yet unclear how LSH is driven to these repetitive or unique 
sequence. It will be therefore important to address this question, in order to fully 
understand the role of LSH in mammalian cells. Analysis of 5meC after depletion of 
H3K9me2 marked heterochromatin shows a possible additive effect on absence of LSH 
(Figure 4.5). It could be hypothesised that deposition of H3K9me2 by G9a could recruit 
LSH-CDCA7 to some loci, which could therefore be methylated and permanently silenced. 
To test this hypothesis, ChIP-qPCR analysis of H3K9me2 could be performed at LSH 
targets genes in Lshoff/off and Lshoff/+ cells, in presence or absence of G9a. If these genes 
showed enrichment in the modification in Lshoff/off and Lshoff/+ cells and were not 
methylated in Lshoff/+ cells in absence of G9a, it would show that H3K9me2 is required for 
recruiting LSH and methylating those specific regions.   
In conclusion, this work has demonstrated that LSH is required for regulating DNA 
methylation in vitro concomitantly with the activation of the de novo methylation at IAPs 
and LINE-1 RE and at a subset of unique sequences, mostly related to features of the 
nervous system. Despite this being just a first step into a better understanding of how LSH 
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plays a role in embryonic development, these results could be launching pad for future 
investigations, providing a limited time window in the development to investigate and 
eventually determining a better understanding of the reprogramming processes of DNA 




7. APPENDIX  
 
BioCAP-seq quality control 
 
Sample Name % Dups % GC M Seqs 
HT_D0_1.1 31.2% 62% 33.1 
HT_D0_1.2 31.4% 62% 33.1 
HT_D0_2.1 40.7% 64% 49.0 
HT_D0_2.2 42.5% 64% 49.0 
HT_D0_input.1 15.1% 41% 53.0 
HT_D0_input.2 14.2% 41% 53.0 
HT_Serum day 4_1.1 30.5% 60% 45.7 
HT_Serum day 4_1.2 30.9% 60% 45.7 
HT_Serum day 4_2.1 34.1% 60% 71.9 
HT_Serum day 4_2.2 36.7% 60% 71.9 
HT_Serum day 4_input.1 14.6% 41% 43.9 
HT_Serum day 4_input.2 14.6% 41% 43.9 
HT_EBs day 8_1.1 39.8% 65% 56.8 
HT_EBs day 8_1.2 43.6% 65% 56.8 
HT_EBs day 8_2.1 36.4% 63% 59.5 
HT_EBs day 8_2.2 40.2% 63% 59.5 
HT_EBs day 8_input.1 14.0% 41% 64.0 
HT_EBs day 8_input.2 14.5% 41% 64.0 
KO_D0_1.1 41.3% 63% 69.3 
KO_D0_1.2 44.4% 63% 69.3 
KO_D0_2.1 40.5% 62% 66.0 
KO_D0_2.2 42.0% 62% 66.0 
KO_D0_input.1 14.0% 41% 82.0 
KO_D0_input.2 15.2% 41% 82.0 
KO_Serum day 4_1.1 30.6% 56% 46.4 
KO_Serum day 4_1.2 31.0% 57% 46.4 
KO_Serum day 4_2.1 30.2% 51% 81.3 
KO_Serum day 4_2.2 31.9% 51% 81.3 
KO_Serum day 4_input.1 14.2% 41% 71.1 
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KO_Serum day 4_input.2 15.3% 41% 71.1 
KO_EBs day 8_1.1 43.4% 60% 75.0 
KO_EBs day 8_1.2 45.5% 60% 75.0 
KO_EBs day 8_2.1 27.0% 54% 71.4 
KO_EBs day 8_2.2 27.5% 54% 71.4 
KO_EBs day 8_input.1 14.6% 41% 73.6 
KO_EBs day 8_input.2 15.2% 41% 73.6 
 
   
Appendix Table 1.BioCAP-sequencing quality control. 
In the first column, samples sequenced are listed: HT = Lshoff/+ KO = Lshoff/off .
In the second column, the percentage of duplicates is indicated.
In the third column, the percentage of GC in each sample is indicated. 
In the fourth column, the milion of reads sequenced per each sample is indicated.  
Appendix 1.BioCAP-sequencing quality control. 
The mean quality value across each base position in the read, obtained with the FastQC quality control
tool. All samples passed the quality control, reaching Phred values higher than 30.   
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(U) Primer pairs for job x80YKQCRDTkqA50GkGa5NOp9qAbHbrMbxg
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(U) Exons for  job urBlVyzAIWgGUrFXvDeVZcYshFfrP59K6g
(U) Primer pairs for job urBlVyzAIWgGUrFXvDeVZcYshFfrP59K6g
Fw Primer Rev Primer
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Primer 1
(U) Primer pairs for job PjTh06jApWiCUjVXODcRZUIsAFdvPxtKbg
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